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Abstract 
The endocannabinoid (eCB) system was found to modulate synaptic transmission in the central 
nervous system (CNS). The retina carries out complex neural computations that involve several 
physiological mechanisms, including short and long-term plasticity phenomena. The mechanisms 
responsible for modifying the strength of retinal synaptic transmission, however, are not fully 
understood. Previous studies in the Vision Lab showed that bath application of a drug that 
elevates the concentration of endocannabinoids reduced the peak amplitude of visual-evoked 
postsynaptic potentials (vePSP) in retinal ganglion cells (RGCs) but paradoxically increased their 
spiking output. In addition, the rise in endocannabinoid concentration shifted the voltage 
dependence of the sodium current to the left. The reduction in vePSP amplitude is consistent with 
the known presynaptic effects of eCBs on synaptic transmission whilst it was postulated that the 
increase in spiking output could be mediated by TRPV1 receptors, which are nonselective ligand 
gated cation channel sensitive to eCBs and a broad range of other stimuli. This study investigated 
the potential role of TRPV1 channels in the modulation of RGCs excitability by recording their 
electrical activity in wild-type and TRPV1 knock-out mice using whole cell patch clamping 
techniques. We found that the endocannabinoid anandamide acts on TRPV1 channels to increase 
cell excitability. Increasing the levels of anandamide in the absence of TRPV1 channels, however, 
led to the activation of RGCs at more hyperpolarised potentials, suggesting that other targets of 
anandamide are involved in RGC modulation. Moreover, the TRPV1 agonist and antagonist 
capsaicin and capsazepine are likely to have non-specific effects as application of capsazepine 
was able to reduce cell excitability in the TRPV knockout mice (TRPV1-/-).  
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1. Introduction 
 
1.1 The Retina 
1.1.1 Introduction 
The retina consists of a complex neuronal network that converts light energy into electrical 
signals containing specific features of the visual world. The retina developmentally originates 
from the same embryonic tissue, ectoderm, as the rest of the brain, and it is therefore classified as 
a part of the central nervous system (CNS). Anatomically, it is the innermost layer of the eyeball, 
lining its posterior curvature. It can be divided into the inner neural layer and outer pigmented 
layer. The inner neural layer contains multiple cell layers and types, responsible for signal 
conversion and processing. The output of this sensory information leaves the retina from the optic 
disk, carried through the optic nerve formed by the ganglion cell axons. In terms of vision, these 
visual signals then travel through the optic nerve, and some axons will cross over at the optic 
chiasm to the opposite side of the brain, continuing as optic tract and reaching the lateral 
geniculate nucleus (LGN) of the thalamus. The retino-recipient neurons from the LGN then 
project to the primary visual cortex and the other cortical areas. This is the visual pathway that is 
involved with conscious visual perception. Other retino-recipient brain nuclei are involved with 
several other non-conscious visual functions such as pupillary reflex, control of circadian rhythms 
and other functions. 
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1.1.2 Retinal cell types and its neural network/organisation 
 
Figure 1.1.Retinal cell organisation and its neural layers. The choroid, pigmented and neural layer of the retina are 
illustrated. The neural layer-formed by three neuronal layers, consists of photoreceptors (rods and cones), bipolar 
cells, and ganglion cells; and two plexiform layers, where neurons synapse with each other (adapted from 
Silverthorn 2013). 
 
 
The retina is a highly organised tissue consisting of three neuronal and two synaptic layers. The 
five main types of neurons are: photoreceptors (rods and cones), bipolar cells, horizontal cells, 
amacrine cells, and ganglion cells. The cell bodies (somas) of different cell types are grouped 
together forming neural layers such that the cell bodies of rods and cones form the outer nuclear 
layer. On the other hand, the somas of horizontal, amacrine and bipolar cells make up the inner 
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nuclear layer, and ganglion cells form the ganglion layer. In addition, there are two synaptic 
layers, also called plexiform layers, where neurons make synaptic contacts with each other.  
Specific wavelengths of light entering the eye can activate photoreceptors where light energy is 
then converted into electrical energy; this constitutes the first step of vision. Photoreceptors first 
transmit visual signals to bipolar and horizontal cells in the outer plexiform layer. Bipolar and 
amacrine cells then make contacts with each other and with the dendrites of ganglion cells in the 
inner plexiform layer. Ganglion cells then send action potentials to different visual areas in the 
brain for further processing.  
Photoreceptors are responsible for the process of phototransduction, in which light is converted 
into an electrical signal. Light first enters the eye via the cornea, passes through the aqueous 
humor, the lens, vitreous humor, then travels through several relatively transparent neuronal 
layers of the retina before reaching the outer segments of photoreceptors (Silverthorn, 2013). 
Rods are responsible for scotopic vision, thus, function best at low light conditions, such as night 
vision, whereas cones are responsible for photopic vision, such as daytime vision and are 
responsible for colour and high-acuity vision. Furthermore, in the primate retina, rods and cones 
have a 20:1 ratio (Mustafi et al., 2009). Rods are mostly located in the peripheral parts of the 
retina and cones are located at the fovea and the central region of the retina. Thus, rods and cones 
enable human to see a wide range of light intensities such as very dim at night or very bright on a 
summer day. 
Old world primates, and humans, have three different types of cones. The cones enable them to 
detect wavelengths from 400nm to 700nm of the visible spectrum. However, cones of other 
animals tend to have different wavelength sensitivities to primates. For example, cones of rodents 
are sensitive to light from 360nm to 510nm, with two cone types containing opsins with distinct 
peak sensitivities, making these animals functionally dichromats (Haverkamp et al., 2005). Thus, 
rodents used in vision experiments require the right wavelengths to stimulate the corresponding 
photoreceptors optimally. 
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Within the retina, there are two main pathways for visual processing: vertical and horizontal.  
The horizontal pathway involves less change in comparison with the vertical pathway. The two 
pathways will be further discussed in later paragraphs (1.1.3). As signals travel down from 
photoreceptors to ganglion cells via the two visual processing pathways, convergence happens. 
Convergence describes when signals from two or more cells synapse onto one cell. In the retina, 
multiple rod and cone photoreceptors synapse to a single bipolar cell. Similarly, multiple rods 
also synapse to a single bipolar cell. There are two main classes of bipolar cells: ON and OFF 
bipolar cells, the former being activated (depolarised) in response to increases in light intensity 
and the later activated in response to decreases in light intensity. ON bipolar cells are depolarised 
by decreases in glutamate release from photoreceptors in response to light stimulation, while OFF 
bipolar cells are hyperpolarised by light (Silverthorn, 2013). Their different responses to changes 
in glutamate concentration are due to different types of glutamate receptors they express in their 
dendritic tips. ON bipolar cells express metabotropic glutamate mGLUR6 receptors in their 
dendrites, whereas OFF bipolar cells express ionotropic glutamate receptors (Masland, 2012).  
Retinal ganglion cells (RGCs) receive synaptic inputs from bipolar and amacrine cells. The cell 
bodies of RGCs constitute the innermost part of the retina. Their axons exit the eye and send 
action potentials to the other areas of the brain for further processing. In other words, ganglion 
cells are the final output neurons of the eye. Thus, the study of the physiological properties of 
RGCs provides a window into how retina process visual information. Rodents, especially mice 
have been widely used to study the properties of ganglion cells. So far, in the mouse, more than 
thirty-two different types of RGCs have been identified (Baden et al., 2016). Different criteria 
have been used to classify RGCs according to their morphological, physiological and, or 
molecular characteristics. Distinct morphological differences have been described based on the 
cell soma size, dendritic tree size, density and branching patterns. Historically, homologous cell 
types in different types of animals have been given different names. Boycott and Wassle (1974) 
proposed one of the earliest morphological classifications relating to the physiological functions 
 13 
of RGCs. Four morphological distinctive cell types were discovered in cat retina: alpha, beta, 
gamma and delta RGCs. They were related to the physiological subclasses: sustained (X), 
transient (Y) and W cells respectively (Boycott and Wassle, 1974).  
 
Alpha cells have large soma size, with branched, widespread dendritic trees. They have been 
found in all types of mammals that have been studied so far, comprising 3% of the entire RGC 
population in cats (Wassle, 2004). In primates, parasol RGCs (M-cells) are suspected to be 
homologous to the alpha cells (Wassle, 2004). Current research has shown three types of alpha 
RGCs in mice: ON sustained, OFF sustained, and OFF transient RGCs (Sanes and Masland, 
2015) with an additional fourth type, On-transient RGC recently discovered (Krieger et al., 2017). 
Another well characterized RGC type is the beta cells. They have a smaller dendritic field, and 
are more densely organized, comprising about half of the total RGC population in cats (Wassle, 
2004). They are thought to be highly involved with the visual acuity system due to the 
aforementioned morphological characteristics. Midget ganglion cells (P-cells) are thought to be 
the homologous version in primates (Sanes and Masland, 2015, Wassle, 2004).  
The physiological classifications will be further discussed in 1.1.4. 
1.1.3Vertical and horizontal visual pathways in the retina 
As previously mentioned, two different processing pathways have been identified in the retina, 
the vertical and the horizontal pathways. In the vertical visual pathway, RGCs receive inputs from 
photoreceptors via bipolar cells. Except for the fovea, neuronal circuits in the retina display a high 
degree of convergence. The fovea is free of blood vessels, and the neurons post-synaptic to 
photoreceptors are laterally displaced, so that photoreceptors receive light directly without being 
scattered or obscured by other structures, and have a one to one relationship with their bipolar 
cells. At the periphery of the retina, 15-45 photoreceptors converge their signals to a single 
bipolar cell, which in turn then passes the signal onto RGCs.  
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On the other hand, in the horizontal signal processing pathway, horizontal and amacrine cells, 
modify signal transmission along the vertical pathway. Horizontal cells receive synaptic inputs 
from photoreceptors and synapse back onto photoreceptors and with bipolar cells. They are 
inhibitory neurons that release GABA and cause lateral inhibition, an adaptation mechanism that 
enables vision under an extensive wide range of light intensities. Amacrine cells synapse onto 
bipolar and ganglion cells, as well as onto other amacrine cells (Masland, 2012).  
Despite these visual pathways, ganglion cells are the recipient of all signals in the retina, they 
then transmit action potentials to the rest of the brain for further processing. Understanding the 
electrophysiological properties of the ganglion cells allows us to understand the early visual 
processing that occurs in the retina. 
 
1.1.4 Centre-surround organisation of receptive fields in the retina 
The receptive field of any sensory neuron refers to the specific region of the sensory space in 
which a stimulus will produce a response in that neuron. In the case of RGCs, light stimulation 
within its receptive field activates their downstream neurons, which pass the signal down to the 
ganglion cell where they elicit a response. In the visual system, Hartline (1938) extended the 
definition of the receptive field to the change of light in a particular area of the visual space that 
can drive electrical responses and elicit neuronal firing in a RGC. The visual field of RGCs can be 
divided into two areas, the centre and the surround (Kuffler, 1953). This organisation of the 
receptive field allows the use of contrast to understand how visual information is processed, as a 
result of the two visual pathways, as well as horizontal and amacrine cells’ inhibitory 
characteristics (Silverthorn, 2013). There are two antagonistic areas in the receptive field of RGC, 
termed the ON and OFF regions as shown in Figure 1.3. Increase in light luminosity in the centre 
or the ON region causes ON cells to fire action potentials. On the contrary, OFF cells fire action 
potentials when the luminosity in the centre or ON region is decreased (dark spot). When light 
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shines on the surrounding region of an ON cell, then the response of the cell is inhibited and stops 
firing. 
 
 
Physiologically, there are three main types of RGCs: ON centre/OFF surround, OFF centre/ON 
surround, and ON-OFF ganglion cells. This refers to their receptive fields’ sensitivity to light as 
each ganglion cell receives visual information from a specific part of the visual field. Figure 1.2 
illustrates the three different response patterns of RGCs. Ganglion cells with ON centre/OFF 
surround receptive field configuration are excited when light stimulates the centre of their 
receptive field, and are inhibited by light shone onto the surround.  ON-type ganglion cells branch 
in the innermost part of the inner plexiform layer of the retina (close to the RGC cell bodies) and 
synapse with the axon terminals of ON-type bipolar cells. The opposite light response occurs in 
OFF centre/ON surround fields, where action potentials occur when the light is removed or 
stimulated by a dark spot. The OFF-type ganglion cells branch in the outermost part of the inner 
plexiform layer of the retina (close to the inner nuclear layer) and synapse with the OFF-bipolar 
cells. Whereas, ON-OFF ganglion cells fire action potentials at the beginning and the end of light 
Figure 1.2. Representation of ON-centre, and OFF-centre receptive fields of retinal ganglion cells.  A. ON-centre, 
OFF-surround receptive field organisation. B. OFF-centre, ON-surround receptive field organisation. (“+” for on, 
“-” for off) 
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stimulation, and their dendritic trees branch in both zones of the inner plexiform layer, making a 
“bistratified” morphology (Nelson, 2007). This organisation uses the difference in contrast 
between the centre and the surrounding part of the receptive field to depict visual information. 
More advanced research methods in recent years have also shown other types of RGCs such as 
brisk transient (Y) cells, direction-selective ganglion cells, colour-coded ganglion cells of the 
primate retina and melanopsin containing ganglion cells (Wassle, 2004).  
A recent review points out the definitive types of RGCs in the mouse are: four types of ON-OFF 
directionally selective cells, three types of ON directionally selective cells, four types of alpha 
RGCs, five types of intrinsically photosensitive melanopsin-containing RGCs, Local Edge 
Detectors, and three types of J-RGCs (Sanes and Masland, 2015). Moreover, there remains many 
identified but yet to be completely characterised RGCs as choosing the right markers remains 
challenging for RGC classification.  
 
  
Figure 1.3. ON-type, OFF-type, and ON-OFF type retinal ganglion 
cell responses to light stimulation (yellow bars). Picture adapted 
fromHartline (1938). 
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1.2 Endocannabinoid System in the Retina 
 
1.2.1 General Characteristics of the Endocannabinoids 
The endocannabinoid system (eCB) of the CNS is a more recently described neurotransmitter 
system that alters neuronal excitability (Schwitzer et al., 2016) and thus, regulates a whole range 
of physiological activities, from pain sensation (Cravatt et al., 2001), motor learning (Kishimoto 
and Kano, 2006), to neuroplasticity and appetite (Di Marzo et al., 2001). Their vast effects on 
physiological processes are due to the fact that the eCB receptors are located throughout the 
central and peripheral nervous systems. The eCB system has already been described in the 
cerebellum (Good, 2007, Kishimoto and Kano, 2006, Di Marzo et al., 2001), hippocampus 
(Hashimotodani et al., 2007, Lee et al., 2015), basal ganglia (van der Stelt and Di Marzo, 2003), 
and other regions of the CNS. eCBs are lipid mediators involved in different biological processes. 
In the body, the most bioactive eCBs are anandamide (arachidonylethanolamide; AEA) and 2-
arachidonoylglycerol (2-AG). Δ9-tetrahydrocannabinol (THC) is the most active cannabinoid of 
the cannabis plant and mimics the action of eCBs. 
 
1.2.2 Neuroplasticity of the Endocannabinoid System 
As previously mentioned, eCBs play a modulatory role in many parts of the CNS, one such role is 
neuroplasticity. Synthesis and release of eCBs occur on demand as the result of increased activity 
in post-synaptic neurons. eCBs are released from postsynaptic neurones and act retrogradely, 
leading to inhibition of presynaptic neuron, and a short-term reduction in postsynaptic activity 
(Middleton and Protti, 2011). Retrograde transmission of eCBs system allows this short-term 
depression effect. Once eCBs are released, they activate presynaptic cannabinoid receptor 1, and 
leads to the hyperpolarisation of the presynaptic terminal, which decreases GABA or glutamate 
release The two most commonly described short-term plasticity phenomena are known as 
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depolarisation-induced suppression of inhibition (DSI) and depolarisation-induced suppression of 
excitation (DSE) (Diana and Marty, 2004). DSI is triggered by postsynaptic depolarisation 
resulting in eCBs release, which induces a transient inhibition of inhibitory neurotransmitters 
(GABA or glycine) from pre-synaptic neurons. DSE functions in a similar fashion, whereby 
release of excitatory neurotransmitters (glutamate) is suppressed. Recent studies by Middleton 
and Protti in 2011 have demonstrated the modulation of synaptic transmission and synaptic 
plasticity in ganglion cells by exo- and endo-cannabinoids.  
 
1.2.3 Endocannabinoids in the Retina: Receptors, Ligand, and Enzymes 
There are two primary types of G protein-coupled eCB receptors: cannabinoid receptor type 1 
(CB1R) and type 2 (CB2R). CB1R receptors have been shown to be present in the retina across 
different animal species such as tiger salamander, goldfish, rat, mouse, chick and monkey 
(Schwitzer et al., 2016). They are found in the main types of retinal cells: photoreceptors, 
horizontal cells, amacrine cells, and ganglion cells (Straiker et al., 1999). The presynaptic location 
of CB1R on glutamatergic and GABAergic interneurons has been widely demonstrated. Their 
modulatory effect on synaptic transmission consists of a reduction in the release of glutamate and 
GABA from presynaptic terminals (Elphick and Egertova, 2001). A recent study by Penzo and 
Figure 1.4. Current models for depolarisation-induced suppression of inhibition (DSI) and 
depolarisation-induced suppression of excitation (DSE). 
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Pena (2009) demonstrated the postsynaptic location of CB1R in adult chick brain as well. CB2Rs 
were found on photoreceptors, horizontal cells, amacrine cells, bipolar cells and ganglion cells 
(Cecyre et al., 2013). Both types of receptors are also present in human retina (Schwitzer et al., 
2016). 
There are two major types of endogenous ligands that stimulate the CB receptors: N-
arachidonoylethanolamide (anandamide, AEA) and 2-arachidonoylglycerol (2-AG). Anandamide 
is synthesised from N-arachidonoyl phosphatidylethanolamine (NAPE). Diacylglycerol (DAG) is 
hydrolysed by two DAG-lipase to produce 2-AG.  
The three enzymes responsible for the degradation of eCBs are fatty acid amide hydrolase 
(FAAH), monoacylglycerol lipase (MGL) and cyclooxygenase-2 (COX-2). In mouse retina, 
FAAH is detected in all major cells types except cones (Schwitzer et al., 2016). MGL has been 
identified in mouse ganglion cells, while COX-2 was shown only in rods and bipolar cells in 
mouse retina, and ganglion cells in rat retina.  
Apart from anandamide’s well-known effect on the eCB system, it was also found to exert 
versatile effects by directly modulating other ion channels as it also binds to the Transient 
Receptor Potential (TRP) family channels. Anandamide is capable of directly inhibiting ion 
currents mediated by L-type Ca2+ channels, and TASK-1 K+ channels (Di Marzo et al., 2002). 
Moreover, recent research (Vardi et al., 2000, Miraucourt et al., 2016) demonstrated that 
anandamide modulates cell excitability by binding to CB1R mediated Na+-K+-2Cl--co-transporter 
(NKCC1) channels. By reducing Cl- level in RGCs, glycinergic currents are increased, which then 
facilitate voltage gated Na+ channels to recover from their inactivation state (Vardi et al., 2000, 
Miraucourt et al., 2016). Membrane potential is then hyperpolarised, which leads to enhanced 
intrinsic excitability of RGCs. Furthermore, anandamide also acts as a endovanilloid, binding to 
the TRP family channels, which will be discussed later under the TRP channel chapter (Chapter 
1.3).   
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Figure 1.5.Modulatory effects of endocannabinoids by retrograde transmission at synaptic terminals. Upon the 
release of neurotransmitters (NTs), binding of NTs to ionotropic (iR) and metabotropic (mR) receptors leads to an 
increase in Ca
2+
 intracellular concentration. AEA (anadamide) or 2-AG (2-arachidonoyl glycerol) is released from a 
postsynaptic neuron, and binds to presynaptic CB1 receptors, which inhibit Ca
2+
channels and activate K
+
channels. 
This in turn decreases NT release. Membrane-transport system (T) takes up the leftover endocannabinoids and 
degrades them via enzymes: fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MGL) and 
cyclooxygenase-2 (COX-2).Picture adapted from Guzman (2003). 
 
A study by Middleton and Protti (2011) demonstrated the application of a CB1R agonist 
WIN55212-2 was able to suppress both glutamatergic and GABAergic currents in ganglion cells. 
Moreover, the same group showed WIN55212-2 could reduce retinal responses to light 
stimulation, which could be reversed by the CB1R antagonist, AM251 (Middleton and Protti, 
2018)  
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Interestingly, recent studies from the Vision laboratory (Protti et al., 2015, Yates, 2014, Leung, 
2016, Yong, 2016) has shown a paradoxical effect when anandamide levels are elevated. This was 
achieved by directly administrating exogenous anandamide and blocking the degrading enzyme 
FAAH using URB597 to retinal wholemounts in the mouse. The physiological or exogenous 
increased level of anandamide was thought to decrease the number of action potentials in RGCs. 
However, by using the patch-clamping technique, the amplitude of light-evoked postsynaptic 
potential was decreased but led to an increase in the number of spikes (Yates, 2014, Protti et al., 
2015, Leung, 2016, Yong, 2016). As the amplitude of the post-synaptic potential represents input 
into RGC and action potential represents the cell’s spike output, this unexpected result illustrated 
URB597 or anandamide increases cell excitability (Protti et al., 2015) as shown in Figure 1.6. 
 
Figure 1.6. Application of URB597 creates a paradoxical effect on retinal ganglion cells. (A)Light-evoked 
postsynaptic potential was reduced after application of URB597 (red trace). (B) Light-evoked response of an ON 
retinal ganglion cell increased in spike count after application of URB597.  
 
  
 22 
1.3 TRP Channels in the Retina 
 
1.3.1 General properties of TRP channels 
Transient Receptor Potential (TRP) channels are relatively non-selective channels permeable to 
cations, including sodium and calcium, with six transmembrane segments, and play important 
roles in sensory physiology. A variety of external stimuli including light, touch, sound, 
temperature and chemical can excite TRP channels. TRP channels were initially discovered due 
to trp mutation in the fruit fly Drosophila, which altered the fly’s electroretinogram resulting in 
missing a sustained phase (Cosens and Manning, 1969). In mammals, TRP channels have a high 
degree of sequence homology, especially in the putative functional regions (Song and Yuan, 
2010). However, they have diverse activation mechanisms, vary in permeability to cations, and 
can be categorised into two groups and a total of seven subfamilies based on their sequence and 
topological differences (Venkatachalam and Montell, 2007). Five channels belong to Group 1 
including TRPC, TRPV, TRPM, TRPA, and TRPN, and two other channels belong to Group 2 
including TRPP and TRPML.  
 
 
Figure 1.7. The TRP superfamily consists of five Group 1 subfamilies and two Group 2 subfamilies.  
They are calcium-permeable cation channels with six transmembrane segments. Picture adapted from 
(Venkatachalam and Montell, 2007). 
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1.3.2 General characteristics of TRPV1 channels 
The Transient Receptor Potential Vanilloid (TRPV) subfamily is divided into two groups: TRPV 
1-4 and TRPV5, 6. TRPV1 is a non-selective ligand-gated cation channel, which can be activated 
by a wide range of physical and chemical stimuli (Chavez et al., 2010, Venkatachalam and 
Montell, 2007). It was first identified by Julius and colleagues in the search for channels activated 
by vanilloid compound capsaicin, which is the hot ingredient from hot chilli peppers (Ryskamp et 
al., 2014). It can also be activated by eCBs, and other exogenous lipids (Leonelli et al., 2009). 
Although it has primarily been located on nociceptive neurons in the peripheral nervous system, 
these receptors have also been found throughout the CNS (Chavez et al., 2010, Leonelli et al., 
2009). Of interest is that Nucci and colleagues (2007) demonstrated the presence of TRPV1 
channels in rat retina through functional experiments. The group discovered anandamide binding 
ability is reduced to CB1 and TRPV1 in ischemic-reperfused retinas, which could induce cell loss 
in RGC layer on ischemic insult. Later, Sappington and colleagues (2009) showed trpv1 mRNA 
was expressed in RGC, with robust TRPV1 proteins localised in the cell bodies and axons. Recent 
research by Jo and colleagues (2017) discovered that TRPV1 expression is confined to a subset of 
ganglion cells, which peaks in the mid-peripheral mouse retina. In addition, their results showed a 
colocalization of CB1R and TRPV1 in RGCs.  
 
1.3.3 Possible explanation of the paradoxical effect observed the RGCs 
One possible explanation for the aforementioned paradoxical effect of URB597 is through the 
activation of TRPV1 channels. As anandamide is a partial agonist for CB1 receptor, but a full 
agonist for TRPV1 receptor, inhibition of FAAH would lead to an increase of eCBs and activate 
not only CB1 receptors but also TRPV1 channels, which have high Ca2+permeability. Increased 
cytoplasmic calcium concentration would activate calcineurin, which is a Ca2+ dependent 
phosphatase implicated in dephosphorylation of Na+channels. This would lead to an increase in 
Na+channels activity and therefore increased action potential firing of ganglion cells.  
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Previous studies from the Vision lab had provided the foundation to the current hypothesis. 
Figure 1.8 illustrates the input-output function of RGCs in response to current injection under the 
effect of URB597 and capsazepine. The input-output function was constructed from current 
injection protocols and describes cell excitability. The number of spikes produced in a RGC was 
plotted as a function of the magnitude of the change in membrane potential for each current step 
and then fitted with a sigmoidal curve. Thus, a shift in the input-output function indicates the 
change in cell excitability.  
 
 As previously mentioned, URB597 is a FAAH inhibitor, which elevates the levels of eCBs, and 
capsazepine is a TRPV1 antagonist. The number of spikes was plotted against amplitude of 
depolarising step for individual cells, and the average input-output function was drawn. A 
leftward shift with URB597 application indicates an increase in cell excitability, which was 
reversed by the application of capsazepine (Figure 1.8).  
 
Figure 1.8.Input-output relationships of ganglion cells in response to current injection under control, URB597, 
and URB+Capsazepine condition. Spike responses were normalised to control condition. Upon URB597 
application, the observed left shift of the curve (green) was reversed by a right shift after application of capsazepine 
(blue). Solid line represents the average of pooled sigmoidal fits, shaded area indicates SEM.  
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Another method to assess membrane excitability is through the analysis of the current-to-voltage 
(IV) relationship recorded under voltage-clamp configuration. This is crucial as the voltage-gated 
Na+ currents are responsible for generating action potentials. As shown in Figure 1.9, the IV 
curve significantly reduced with URB597 application, which indicated raised level of Na+ entry 
and spike output.  
 
 
Figure 1.9.Current-voltage (IV) relationships illustrate a left shift in Na+ entry from control after application 
ofURB597, then a right shift from URB to URB+Capsazepine. The average IV plot (±SEM), normalised to peak 
Na+ current is shown. Amplitude of Na+ entry was plotted against membrane potential of RGCs as IV curves. A 
leftward shift was observed with URB597 (green trace) condition followed by a rightward shift upon capsazepine 
(blue trace) application.  
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1.4 Hypothesis and Aims 
 
The overall aim of this project was to investigate the roles that TRPV1 channels play in the 
modulation of membrane excitability in RGCs, in particular, their possible involvements in the 
eCB system. The specific aims are:  
1. To study the effects of TRPV1 channel agonist capsaicin on RGC excitability. Since 
TRPV1 channels are nonselective ligand gated cation channels, we predict bath 
application of capsaicin on retinal whole mounts will cause an influx of cations into 
ganglion cells, leading to an increase in their excitability. 
2. To determine the effects of anandamide on TRPV1 channels and its modulation of RGC 
excitability using URB597 and capsazepine. As anandamide is an agonist of TRPV1 
receptors, an increase in ganglion cell excitability is expected. URB597, a FAAH 
inhibitor, elevates the levels of eCBs and leads to an increase in cell excitability, thus, its 
effects are expected to be reversed by the co-application of capsazepine (TRPV1 
antagonist). Thus, little or no change in ganglion cell excitability is expected. 
3. To further validate Aim 2 by using TRPV1-/- knockout mice. In these knockout animals 
where TRPV1 channels have been removed, results could be compared to those obtained 
from control animals. Differences between these groups could reveal other functions of 
TRPV1 channels. 
The above aims will be achieved by pharmacological modulation on the eCB system in wild-type 
(control) and TRPV1 knock-out mice. Patch clamp technique was employed to obtain 
electrophysiological recordings from the cell bodies of RGCs. Cell excitability will be examined 
by generating input-output functions from current clamp recordings, and Na+ and K+ currents will 
be recorded under voltage clamp configuration to produce current-to-voltage (IV) relationships. A 
mouse model was chosen for the current study based on the following reasons: 1) Results 
collected could be compared to the data obtained from previous experiments conducted by the 
 27 
same lab. 2) Mouse is a common animal model thus allows comparison to published results. 3) 
Genetically modified TRPV1-/- mice are accessible. 
Based on background knowledge, it was hypothesised that: TRPV1 channel activation by eCBs 
leads to an increase in RGC excitability. Application of a TRPV1 agonist (capsaicin) and an 
antagonist (capsazepine) were used for wild type animals. To test whether or not the URB-
induced postsynaptic effects are mediated by TRPV1 channels, URB597 in combination with 
TRPV1 antagonist capsazepine was used for TRPV knockout animals. If anandamide-induced 
increase in cell excitability was due to binding of TRPV1 channels, we hypothesise the following:  
 
1. Application of capsaicin will increase cell excitability. Na+ and K+ current will increase in 
amplitude, X-half of the input-output function will decrease, and spike output will increase.  
2. Application of capsazepine will modify cell excitability, changing Na+ and K+ currents and 
the input-output function.  
3. Using knockout animals, where TRPV1 channels are absent, application of URB597 elevates 
the level of anandamide but no effects on RGC excitability would be seen if anandamide acts 
via TRPV1 channels.  
4. In the absence of TRPV1 channels, co-application of URB597 and capsazepine on knockout 
animals is not expected to produce any change in cell excitability.  
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2. Materials and Method 
 
2.1 Ethics Approval 
Procedures and experimentation on all animals used were approved by the Animal Ethics 
Committee of the University of Sydney. Guidelines issued for animal experiments by the 
Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, and National 
Health and Medical Research Council of Australia, were followed.  
 
2.2 Solutions Used in Experiments 
An extracellular solution was made up of 8.8g of AMES medium (US Biological) and 1.9g of 
sodium bicarbonate in 1L of Milli-Q water. It was used to bath the retina for dissection and 
electrophysiological recordings. AMES medium is made of many inorganic salts, amino acids, 
vitamins, and other compounds to keep the retina alive after dissection as well as maintaining its 
electrical activity. The extracellular solution was continuously bubbled with 5% carbon dioxide 
and 95% oxygen to buffer the solution at pH of 7.4 while keeping the retinal tissue oxygenated.  
 
Intracellular solution used for electrophysiological recordings consisted of: K+-Gluconate 
(140mM), HEPES (10mM), EGTA (10mM), MgCl2 (4.6mM), ATP-Na+ (4mM), and GTP-Na+ 
(0.5mM) (Huang et al., 2013). The osmolarity was kept around 278mOsm, about 10mOsm lower 
than the extracellular solution in order to help giga-seal formation between the tip of the 
micropipette and the cell membrane. 1% (in volume) of fluorescent dye Lucifer yellow was also 
added to the intracellular solution prior to patching for the purpose of morphological 
identification of cells and antibody staining.  
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2.3 Tissue Preparation 
Two mouse strains were used for the experiments, C57bl/6J (N = 30) were used as wild-type 
(control) animals and TRPV1-/- (B6.129X1-Trpv1tm1Jul/J, N = 48) were used for the knockout 
experiments. The TRPV1-/- mouse line was obtained from Prof. Bernard Balleine. These mice are 
homozygous for the targeted mutation; their phenotype is normal but they display no pain 
response and show reduced aversive responses to high temperature and acidity. These mice live 
longer than wildtype mice, maintain a youthful metabolic profile, and have improved special 
memory (Caterina et al., 2000). 
Animals were dark adapted for at least 2-hours before anaesthesia with isoflurane (Henry Schein) 
followed by euthanasia by cervical dislocation in the dark under infra-red illumination or under 
dim red light. Infra-red viewers (FJW Optical Systems, Find-R-Scope Infrared) attached to a 
microscope (Olympus SZX7) allowed visualisation of the eye structures and the retina while 
dissecting in the dark. Eyes were removed using curved scissors and transferred to a beaker 
containing AMES solution and then to a Petri dish with AMES solution continuously 
carboxygenated. Dissection of the eye was done under a microscope (Olympus SZX7), after 
removal of the cornea and iris, lens was taken away for retinal detachment from the sclera. Before 
detachment of the retina, the eyecup was cut into halves to harvest hemi-retinae. This cut flattens 
the retina, so that it can be put under a grid where it remains relatively flat. Afterwards, vitreous 
humour was carefully removed from the retina without damage. One hemi-retina was mounted 
inside a recording chamber with the ganglion cell layer up, and held down by a grid made of 
platinum wire and dental floss threads.  
The chamber was then placed under an upright microscope (Olympus BX50WI), and 
continuously perfused with carboxygenated extracellular solution. A CCD camera (JENOPTIK 
D-07739) was connected to the microscope and computer monitor to allow visualisation of the 
tissue under infrared light (see Figure 2.1).  
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2.4 Electrophysiological Recordings made from Ganglion Cells 
In order to carry out electrophysiological recordings, physical access to the cell body is required. 
This was achieved by firstly tearing a small hole in the inner limiting membrane to expose the 
soma of ganglion cells using a pulled glass pipette driven by a micro-manipulator (Sutter MP-
225). Next, a newly pulled glass pipette of resistance 6-10MΩ was filled with intracellular 
solution containing the fluorescent dye Lucifer yellow. Positive pressure was applied before 
entering the bath with the pipette, which was used to approach and target RGCs using a 
micromanipulator. The pipette was then lowered onto the soma surface until a dimple was visible. 
The positive pressure was subsequently released, and negative pressure was gently applied to 
achieve a giga-seal. After obtaining a giga-seal, a short pulse of negative pressure was applied 
until the cell membrane opens. Membrane potential was maintained at -60mV before performing 
several recording protocols using an EPC8 patch clamp amplifier (HEKA Electronik). 
PatchMaster software was used, protocols were then repeated under different pharmacological 
conditions, as described below.  
Figure 2.1. Experimental setup for patch clamping mouse retinal tissue and data acquisition. Visualisation of 
the cell body is gained by infrared light imaging captured by a digital camera, and relayed to the computer. 
Cell membrane potential is kept stable (~ -60mV) using a feedback loop between the computer and the cell and 
injecting different amount of currents (voltage clamp mode). The same feedback loop is also used to inject 
constant current. Cell responses such as amplitude of the changes in membrane potential and spikes were 
acquired, amplified and recorded. Recordings of the cell is displayed in red on the right screen. 
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2.5 Protocols Used to Make Recordings from Ganglion Cells 
 
2.5.1 Voltage clamp protocols used to stimulate ganglion cells 
To explore the effects of pharmacological modulators of the endocannabinoid system and agonist 
and antagonist of TRPV1 channels on RGCs excitability, RGCs were held from -75mV to 
+35mV, at intervals of +10mV for 100ms. A total of 12 steps were applied to the cell. Note that 
there were changes made to the protocol to achieve better resolution around the peak inward Na+ 
current. The cell membrane holding potential changed from 12 steps to 24 steps as shown in 
Figure 2.3. After modification of the membrane holding potentials, RGCs were held at intervals 
of +5mV for the first 12 steps and intervals of +10mV for the following six steps for 100ms as 
shown in Figure2.3B. The peak amplitude of inward Na+ currents from each step was extracted 
later to build current-to-voltage (IV) curves.  
While whole-cell patch clamp technique is widely used for synaptic electrophysiological studies, 
direct dendritic recordings have exposed the space-clamp error of the voltage clamp (Williams 
Figure 2.2. Representative voltage clamp membrane currents with depolarisation recorded from the 
cell body of a ganglion cell. (A)The inward Na+(downward) and outward (upward) K+ currents 
representation from a typical ganglion cell are shown. (B) Stimulation of a ganglion cell was achieved 
using currents ranged from -75mV to +35mV with 5mV steps for 100mselicited inward 
Na+(downward) and outward (upward) K+ current corresponds to A. 
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and Mitchell, 2008). This error is due to neurons are not perfectly spherical, and somatic patch 
clamp could only have accurate control of the membrane potential of the somatic and perisomatic 
area. The apical dendritic voltage escape could sequentially distort the somatic measurement 
(Williams and Mitchell, 2008). This will be further discussed in Discussion (4.3).  
 
2.5.2 Current-injection protocol into the cell bodies of ganglion cells 
Apart from current injections or during experimental protocols, the resting membrane potential of 
the cell was always kept at -60mV. Any current required to inject into the cell corresponds to the 
leak current.  
In order to investigate the excitability properties of ganglion cells in current-clamp configuration, 
24 current steps at increment of +5pA amplitude was applied. Currents ranged from +15pA to 
125pA were injected for 100ms into the cell bodies of RGCs to elicit action potential firing as 
shown in Figure 2.4.  
 
Figure 2.3 Holding potentials of ganglion cells under voltage clamp configuration. (A). There was a 
total of 12 steps of holding potentials ranged from -75mV to +35mV at intervals of 10mV for 100ms. 
(B). First 12 steps of holding potentials ranged from -75mv to +5mV with 5mV intervals and six steps 
of holding potentials from +5mV to +35mV at interval of 10mV for 100ms 
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2.5.3 Light-stimulation protocols used to stimulate ganglion cells 
Two protocols were used to measure light evoked responses in current clamp mode.  
The first protocol consisted of five light stimuli of similar light intensity. This was achieved by 
applying full field stimulation with a blue (455nm) LED (THOR LABS DC 4104) at an intensity 
of 1.1210 photons/µm2*s through the microscope optics (2.24 x 107 photons/um2/s with ND6, 
ND10 and polariser filters). Following this, another stimulation protocol was applied in which 10 
constant intensity light pulses of varying duration (range: 2.25ms - 192.5ms) were applied. 
 
2.6 Data Analysis of Ganglion Cell Responses 
Custom-written routines in IGOR Pro 6.0 (Wavemetrics) were used to analyse 
electrophysiological recordings obtained from Patchmaster (HEKA Electronik). Input-output 
functions of ganglion cells were built from spike output and amplitude of depolarisation/light-
evoked postsynaptic potential were recorded under current clamp mode. The relationships alone 
Figure 2.4 Sample recording traces of current injection recorded from a typical ganglion cell. 
Sample action potentials in response to four steps of current injections (60, 65, 70, 75 pA).   
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with their key parameters were further normalised and pooled to compare between different 
pharmacological conditions. 
2.6.1 Current-voltage relationships and inward Na+ currents of ganglion cells 
 
 
Figure 2.5 Analysis of a voltage clamp trace recorded from a ganglion cell illustrating parameters collected for 
further data analysis. a: the amplitude of inward Na+ current;b: the amplitude of outward K+ current; c: the number 
of inward Na+ spikes. 
 
Voltage gated Na+ and K+ channels open at different membrane holding potentials, moving in the 
opposite directions. Positive K+ currents (b) leaving the cell can be seen in Figure2.5 as an 
upward deflection of the membrane potential, and positive Na+ currents (a) going into the cell will 
be indicated as the downward deflection. Also, Na+ and K+ channels have different kinetic 
properties and opening at different rates, with Na+ opens much faster than K+ channels (Hodgkin 
and Huxley, 1952). Amplitudes of both inward Na+ and outward K+ were measured for the control 
and two pharmacological perfusion conditions (Figure 2.5). Then each amplitude was plotted 
against the corresponding holding voltage for the construction of current-to-voltage (IV) plots and 
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subsequent quantification of V-half. V-half represents the value at half-height which is 50% of the 
maximum Na+ current (see Figure2.6).  
 
 
Figure 2.6 Sample trace of an IV curve of inward Na+ and outward K+ current amplitude (y-axis) in response to 
membrane depolarisation (x-axis). The dash line indicates V-half which is 50% of the maximum Na+ current.  
 
The amplitude of maximum inward Na+ current, 50% of the maximum Na+ current (V-half), the 
total number of inward Na+ events, and the peak outward K+ current were extracted from the IV 
curves. A two-tailed Wilcoxon matched-pairs signed rank test was performed between the control 
and the first drug condition, as well as between the first drug and the second drug conditions.   
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2.6.2 Pulse 
 
A short change of -10mV in the holding membrane potential allows direct observation of change 
in cell access measured under voltage clamp, as shown in Figure 2.7. This measurement is crucial 
for comparison of cell access before and after each pharmacological condition.  A dramatic 
change in cell access could lead to poor quality of electrophysiological recordings, resulting in 
large alteration in RGC excitability. Such cells were eliminated as not to confuse their results with 
the actual effects of drug perfusion.  
 
2.6.3 Current injections into the cell bodies of ganglion cells 
In order to generate the input-output functions of RGCs, measurements of the amplitude of 
membrane depolarisation and the number of action potentials (spikes) were obtained. A threshold 
of -30mV was set to detect spikes. Amplitude of the depolarisation was measured by removing 
spikes using linear interpolation of the membrane potential 4ms before and around 10ms after 
Figure 2.7 Amplitude of the inward current was measured to indicate the degree of cell access. Cell 
access for the control and the two pharmacological conditions were measured for the purpose of 
examining stability of recordings, and thus ruling out that changes in excitability were due to differences 
in electrical access to the recorded cell.  
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each spike (Di Marco et al., 2009). The difference between resting membrane potential and peak 
depolarisation is measured as ΔVm. For the construction of the input-output plots, the number of 
spikes is plotted against ΔVm and was fitted with a sigmoidal function: !"#$ + &"'1 + exp 'ℎ"-. − ' 0"1$  
 
base: the minimum point of output, where the sigmoidal curve crosses the y-axis. 
max: the maximum point of output, where the sigmoidal curve plateaus. 
x-half: the membrane potential (x-axis) when 50% of maximum output occurred. 
rate: the slope of the sigmoidal curve. 
 
 
Figure 2.8 Analysis of a current injection trace recorded from a typical ganglion cell. Amplitude of the 
membrane potential and the total number of spikes measured at threshold of -30mV were used for further 
data analysis.  
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The total number of spikes were measured directly between time interval indicated by the bottom 
trace in Figure 2.8. Amplitude of the depolarisation was measured after smoothing out spikes at 
the set threshold of +30mV (Figure 2.9). As neuronal input-output relationship is described by 
sigmoidal curve function, a curve fit generated for individual RGC (Rudolph and Destexhe, 2006, 
Lafon et al., 2017, Hocking, 2016). Also, this approach enables the comparison across multiple 
cells as explained in the following paragraph.  
 
 
 
 
  
Figure 2.9 Sample trace of current injection of a typical ganglion cell after smoothing. Action potentials 
were removed, the smoothed curve was used to measure the change between resting membrane potential 
and depolarised potential (ΔVm).  
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Parameters of individual sigmoidal fits were then collected from the input-output curves, which 
were first normalised against control condition, pooled and then averaged. Procedures are as 
follows: first, fits were regenerated by using the sigmoidal function parameters: base, max, x-half 
and rate as shown in Figure 2.10. Next, they were normalised to the maximum amplitude, aligned 
to X-half and averaged to generate the mean input-output function for control and different drug 
conditions. The mean function of the drug condition was first normalised against one for its 
maximum value to compare the change in X-half. Then, the drug condition sigmoidal fit was 
further normalised against the control condition in regard to each maximum spike output value to 
directly illustrate the change in maximum output. A two-tailed Wilcoxon matched-pairs signed 
rank test was performed to compare X-half (half-height) of the control and drug conditions.  
 
2.6.4 Light responses collected from ganglion cells 
Quantification of light-evoked responses was made in a similar way to that of the aforementioned 
current injection analysis. Amplitude of membrane potential and total number of action potentials 
in response to light stimulation were measured (see Figure2.11).  
Figure 2.10 Spike-amplitude relationship curve. Number of spikes output was plotted against 
amplitude of depolarisation. A sigmoidal curve was fitted through data points with curve 
parameters indicated on the top left-hand corner of the figure. Sigmoidal curve fitted parameters 
were collected for further statistical comparisons between control and various conditions. 
 40 
 
 
For wide field constant luminosity and constant duration light stimulation (5ms duration) protocol 
(Figure2.11), direct statistical analysis was performed for the average of amplitude of light 
evoked post synaptic potential (LE-PSP) and total number of spikes. 
For wide field constant luminosity with increase stimulus duration protocol (Figure 2.12), input-
output sigmoidal functions were generated. Figure 2.13 demonstrates five sample RGC responses 
with its’ corresponding light stimulation of various duration. Further, Figure 2.14 demonstrates a 
sample response of a single RGC to the increasing light duration. In a similar way to the statistical 
analysis for current injection protocols, sigmoidal parameters were used to reconstruct curves, 
which were then normalised and pooled. Statistical analysis was performed to compare X-half in 
order to compare RGC excitability. 
 
 
Figure 2.11 Sample trace of light response recorded from a typical ganglion cell. Action 
potential firing in response to blue LED light stimulation (5ms) was quantified to obtain the 
total number of spikes and amplitude of the light evoked post synaptic potential (LE-PSP). 
 41 
 
 
  
Figure 2.12 Duration of ten light stimulations of the same intensity. Stimulation time is listed as following: 
0.00525s, 0.00775s, 0.0115s, 0.01725s, 0.0255, 0.03825s, 0.05725s, 0.08575s, 0.1285s, 0.1925s.  
Figure 2.13 Five sample traces of RGC response to same intensity different duration light stimulation. 
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1.6.5 Statistical analysis 
Different statistical tests were used to analyse statistical significance between control and drug 
conditions. For paired data comparison, two-tailed Wilcoxon tests were used to analyse the 
change in X-half for input-output function, V-half, peak Na+, peak K+ currents and total number 
of Na+ events were extracted from the I-V relationship. This statistical test was used due to the 
variability between each ganglion cell response and the non-normal distribution of data. As for 
presentation, Box-and-whisker plots were used, presenting median, first and third quartiles, along 
with the minimum and maximum data points. The Kolmogorov-Smirnov tests were used for 
comparison between sigmoidal fits (normalised to one) for input-output functions built from 
current clamp recordings. This test can detect overall differences including shift, slope, and shape 
of the input-output functions between control and drug conditions, rather than single point 
comparison of X-half values.  
 
2.7 Morphological analysis to determine ganglion cell types  
As previously mentioned, 1% fluorescent dye Lucifer Yellow was included in the intracellular 
solution. The dye fills up the cell, which allowed us to obtain information about the morphology 
Figure 2.14 Sample relationship of the RGC response (number of action potential spikes) to 
increased light stimulation of the same intensity. Spikes counts were generated using the 
same method described in 2.6.3. 
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of the patched cell. Upon finishing electrophysiological recordings, the micropipette was carefully 
retracted from the cell minimising damage to the cell body. The retinal tissue was then fixed with 
4% paraformaldehyde for 30 minutes, followed by three phosphate buffer saline (PBS) washes at 
ten minutes’ intervals. Afterwards, the tissue goes through antibody staining as follows: 
i. Five days of incubation of retinal tissue with anti-Lucifer yellow antibody (rabbit IgG, 
1:10000, Invitrogen). 
ii. On the fifth day, wash the tissue in PBS for at least eight hours. 
iii. Sixteen hours’ incubation of Alexa594 conjugated to goat anti-rabbit IgG (1:500, 
Invitrogen) followed. 
iv. Mounting of the tissue with FluorSave medium (Merck Millipore) for confocal imaging.  
After obtaining microscopic images using a Leica SPII confocal microscope, images were 
stitched using Image J. Classification parameters developed by (Sun et al., 2002) including soma 
size, dendritic field size of the ganglion cells to obtain quantitative data. These parameters were 
measured in ImageJ, and the current study classified RGCs into four subcategories: A, B, C, and 
D. A-type has a dendritic diameter of around 300µm and a radiant dendritic branching pattern. B-
type has a dendritic diameter around 173µm and a dense dendritic branching pattern. C-type has 
an average dendritic field diameter of 241µm and less dense dendritic tree. D-type have thin 
curvy dendrites and an average of 150µm dendritic diameter. Cells that did not fit the above 
criteria were grouped as unclassified. 
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3. Results 
3.2 The effects of capsaicin on retinal ganglion cell properties in wild type mice 
To investigate the potential involvement of TRPV1 channels on RGC excitability, 
electrophysiological recordings were obtained in response to current injection and voltage clamp 
protocols before (control) and after perfusion with the TRPV1 channel agonist capsaicin (CAP). 
Input-output functions that describe cell excitability were constructed from current injection 
protocols by quantifying the number of spikes elicited in a RGC as a function of the magnitude of 
the change in membrane potential for each current step. To assess the voltage dependence of Na+ 
currents, current-to-voltage (IV) relationship was analysed in response to the different cell 
holding potentials.  
 
Physiological responses were recorded from different types of RGCs. From a total of 79 RGCs 
that were electrophysiological recorded, 25 cells were morphologically identified after 
visualisation and scanning under a confocal microscope. Ganglion cells were classified into four 
subgroups: A, B, C or D according to criteria published by Sun and co-workers (2002). Due to the 
relatively limited number of cells of each subgroup successfully patched and morphologically 
identified, we were not able to analyse the correlation between morphological classification and 
electrophysiological properties. Furthermore, we are only confident about three main 
morphological type classifications: A, B, and C as we rarely patched D cells although cells were 
chosen randomly. Figure 3.1 shows representatives of the three main RGC subtypes. Figure 3.1A 
is an A-type RGC with a soma diameter of 16.7 µm. It has four primary dendrites displaying 
relatively even pattern covering a large dendritic field. Figure 3.1B illustrates a B type RGC with 
a soma diameter of 15.2 µm, with a small dendritic tree localised distinctively unilaterally. Figure 
3.1C represents a C-type RGC, with 12.6 µm soma diameter and a medium sized dendritic field. 
This particular cell has a comet-like aspect which is characteristic of the C6 subtype of C cells.  
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3.2.1 Input-output relationship in response to current injection  
In order to examine the impact of capsaicin on the excitability of ganglion cells, the current 
injection protocol was used. The mean input-output function was constructed using RGC spike 
output and EPSP. The figures below display representative recordings and stimuli and 
demonstrate the construction process of the input-output curves.  
Figure 3.2 shows representative recordings of the response of a RGC to injection of a current step 
before and after bath application of the TRPV1 channel agonist capsaicin (10 µM). A 
concentration of 10 µM was chosen because preliminary studies performed by Yong (2016), 
Leung (2016) showed it was effective in modifying the excitability properties of RGCs. The 
strength of the responses to current injection was increased upon bath application of capsaicin. In 
Figure 3.1. Photomicrographs showing example cells of each of the three main ganglion cell morphological 
types. (A) An A-type RGC with a large dendritic field. (B) A B-type RGC with thin, curvy dendrites and a small 
dendritic field. (C) A C-type RGC with dendrites extending in one direction and of a large dendritic field.  
 
 46 
the control condition, the total number of spikes was 10 compared to 16 spikes during drug 
condition - an increase of 60%. 
 
 
 
Current injection protocols were applied to RGC in control and capsaicin conditions to generate 
input-output functions. RGCs were first recorded under control conditions with 12 steps of 
currents injected into the RGC while holding membrane potential at -60mV. The total number of 
spikes was counted in both control and capsaicin conditions as illustrated in Figure 3.2. The total 
number of spikes (y-axis) was then plotted against the change in membrane potential (ΔVm on x-
axis), and fitted with sigmoidal curves. Thus, these curves represent the cell’s input-output 
function as shown in Figure 3.3.  
Figure 3.2 Representative spike output in response to the same level of membrane depolarisation under 
control and capsaicin conditions from a single RGC. It is clear that application of 10 µM capsaicin (red trace 
on the right) increased the number of spikes. 
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Subsequently, by using parameters obtained from each sigmoidal fits, two normalised input-
output functions were generated using custom-written routines in IGOR Pro 6.0 (Wavemetrics) 
for all cells recorded in both control and capsaicin conditions. Control input-output functions 
were pooled, aligned to their X-half and averaged as shown in Figure 3.4A. Note that similar 
procedures were carried out with input-output functions generated for capsaicin treatment. In 
Figure 3.4A, input-output function of capsaicin condition was normalised against the maximum 
output in control condition, to compare the maximum spike output in the presence of capsaicin 
against control conditions.  
Figure 3.3 Representative input-output relationships in response to current injection from a single RGC 
under control and capsaicin conditions. The total number of spikes is shown on the y-axis, it is plotted against 
the change in membrane potential (ΔVm) on x-axis and are shown as dots. Solid lines represent fitted sigmoidal 
curves under control condition (black) and under capsaicin condition (red). A leftward shift of the sigmoidal 
curve in capsaicin condition reflects an increase in spike output at similar level of ΔVm. 
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Figure 3.4. Current injection responses in control and capsaicin conditions (n = 7). (A) Input-output 
relationship in response to current injection in control and capsaicin condition, normalised to control. Spike 
output on the y-axis is plotted against ΔVm, which represents the difference between resting membrane 
potential and depolarisation potential. A slight right shift from control to capsaicin condition in the mean fitted 
curve is shown. (B) Input-output relationship in response to current injection in control and capsaicin 
condition, normalised to 1. Kolmogorov-Smirnov test showed a statistically significant overall difference in the 
input-output relationship between the two groups (p < 0.0001). (C) A magnified section of input-output function 
from (B) for 0 to 25mV of ΔVm. An increase in output for the same ΔVm can be clearly demonstrated in this 
magnified insert.  
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After the addition of capsaicin (10µM) to the bath,  the mean input-output relationship of seven 
RGC exhibited no apparent change in maximum spike output. However, as shown above in 
Figure 3.4A, at lower input levels (below 15 mV) RGCs recorded in the presence of capsaicin 
had a higher level of spike output. This can be clearly seen when both mean input-output curves 
were normalised to 1 in Figure 3.4B and Figure 3.4C. In particular, when the early rising phase 
of the curve is magnified in Figure 3.4C, a stronger spike output for the same amount of change 
in membrane potential can be observed upon application of capsaicin. 
Figure 3.4B shows that there is no change in X-half values. Under control condition, derived X-
half value was at 17.5 ± 0.29 mV and in the presence of capsaicin it was 18.0 ± 0.49 mV, these 
values were found to be not statistically significant (Wilcoxon test, n=7, p > 0.1; see Figure 3.5). 
Figure 3.5 illustrates X-half for the control and capsaicin conditions using box-and-whisker plot.  
The advantage of using box plot is median, first and third quartiles, the minimum and the 
maximum data points are all represented on each plot providing more information. In conclusion, 
Capsaicin produced an increase in output for the same ΔVm from 0 to 25mV, but no change in X-
half could be seen. 
 
  
Figure 3.5. Capsaicin produced no change in the mean X-half (n=7, 
p > 0.05) for a population of seven ganglion cells. No statistical 
significant change is see (Wilcoxon test: p > 0.1).  
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3.2.2 Effects of capsaicin on the current-to-voltage relationships in RGCs 
Current-voltage (IV) relationships for Na+ and K+ currents were recorded in control condition and 
after bath application of capsaicin (Figure 3.6). In the representative Figure 3.6, after bath 
application of capsaicin, Na+ current had fewer inward currents spikes, and their maximum 
amplitude was smaller. IV curves allowed us to assess the potential involvement of TRPV1 
channels in modulating the excitability properties of ganglion cells. RGCs were held at 12 
different voltages from -75mV to +35mV with +10mV per incremental step. Peak inward Na+ and 
K+ currents in response to each holding membrane potential were quantified and plotted against 
holding potential of each step as shown in Figure 3.7. 
 
 
 
  
Figure 3.6 Representative single voltage clamp recording trace of Na+ and K+ currents for a single RGC 
under control and capsaicin conditions. For this cell, there was a small reduction in peak Na+ current and 
reduced inward Na+ events. No obvious change in K+ currents could be seen. 
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To generate a normalised IV relationship, Na+ and K+ currents of each cell were divided by their 
peak Na+ and K+ currents respectively. Then, an average of the individually normalised currents 
was taken across the 12 recorded RGCs to produce the final normalised IV relationship as shown 
in Figure 3.8. Four properties of IV relationship in ganglion cells were examined. They were: 1) 
the total number of inward currents carried by Na+ (Na+ events), 2) the peak amplitude of Na+ 
current, 3) the membrane potential at which 50% of the peak Na+ current was reached (V-half), 
and 4) the peak amplitude of the outward K+ current.  
 
Under control condition, Na+ currents were activated at a holding potential around -55mV, and 
reached a maximum mean value of -2.07 ± 0.28 nA (n=11) at -50mV (Figure 3.8). After bath 
application of capsaicin (10µM) for 5 minutes, the magnitude of the Na+ current observed 
at -55mV increased, producing a steeper slope which shifted the V-half to the left, as shown in 
Figure 3.9A. The Na+ current reached a peak current of -1.71 ± 0.174 nA (n=11) also at -50mV 
Figure 3.7 Representative current-to-voltage (IV) relationship obtained from a ganglion cell in control 
(black) and capsaicin (red) conditions. Na+ ( triangle) and K+ (circle) currents were plotted against various 
holding membrane potentials to build an IV relationship. For this ganglion cell, there was a reduction in peak 
inward Na+ current, as well as a small increase of the peak outward K+ current. 
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but it was significantly reduced (p < 0.05) in size compared to the control condition as seen in 
Figure 3.9B. No significant difference was found in the total number of Na+ events as illustrated 
in Figure 3.9C and in peak K+ current in Figure 3.9D. 
The finding of Na+ potential indicates capsaicin allows RGCs to be activated at more 
hyperpolarised potentials, though producing a smaller amplitude. And capsaicin produced no 
change in K+ channel.    
Figure 3.8 IV responses of RGCs in control (black) and capsaicin (red) conditions (n = 12).  IV relationship 
shows a larger Na+ (dot) current at a lower holding membrane potential under capsaicin condition. Amplitude 
of Na+ and K+ (triangle) current entry was plotted against membrane potential of RGCs to produce IV curves. 
Average IV curves (± SEM) normalised to peak Na+ and K+ are shown.   
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3.3 The effects of capsazepine on retinal ganglion cell excitability properties in wild 
type mice 
To further investigate the involvement of TRPV1 channels, the antagonist capsazepine was used 
to compare RGC excitability properties with the control condition. A concentration of 10 µM was 
chosen based on values used in the literature. Therefore, one would predict after application of 
capsazepine, the responses of the cell would be similar to those obtained from the control 
condition. Previous experiments from the Vision lab (Middleton and Protti, 2012; Yates, 2014) 
showed that eCB are constitutively released in the retina. Based on eCB binding to TRPV1 
Figure 3.9 Application of the TRPV1 channel agonist capsaicin changes excitability of ganglion cells. (A) A 
significant reduction in V-half was observed with application of capsaicin (p < 0.05). (B) A significant decrease 
in peak Na+ amplitude was observed under capsaicin condition (p < 0.05). (C) Little change in the total 
number of Na+ events were observed with capsaicin (p > 0.05). (D) No significant change can be seen in peak 
K+ current between control and drug conditions (p > 0.05).	
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channels and producing an increase in excitability in RGC, TRPV1 antagonist capsazepine was 
hypothesised to reduce RGC excitability.  
 
Similar to the experimental design used to study the effects of capsaicin, input-output functions 
and current-to-voltage relationship were extracted and analysed. However, some modifications 
were made to the stimulation protocols. For current injection protocols, the duration of the current 
steps was shortened from 0.5s to 0.1s, and smaller intervals of 5pA rather than 10pA between 
steps were used to obtain a better estimate of V-half value. A total of 24 current steps were 
injected to examine spike output of RGCs. This modification enabled recordings to be made in 
order to detect smaller changes in membrane potential and to avoid plateau of spike output and 
over stimulation of the cell. The current-to-voltage protocol was also modified to deliver smaller 
holding potential intervals to produce a better resolution at peak Na+ current.  
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1.3.1 Input-output relationship of ganglion cells 
To examine the effect of capsazepine on RGC excitability, current injection protocol was used to 
record RGC’s spike output and EPSP for both control and capsazepine conditions.  
The input-output function of ganglion cells after application of capsazepine, produced with the 
modified protocol, had a significantly smaller number of spikes due to shorter duration of 
stimulation in comparison with the capsaicin results from previous section. In general, no change 
was found in the parameters characteristic of the input-output relationship. Wilcoxon test shows 
no difference in maximum spike output (p > 0.05, n = 14) despite Figure 3.10A visually shows a 
small reduction in the maximum spike output. As for the X-half, Figure 3.10B shows no change, 
which is confirmed by Wilcoxon test in Figure 3.11 (p > 0.05, n = 14). 
 
 56 
 
 
Figure 3.10. Current injection responses of ganglion cells in control (black) and capsazepine (blue) 
conditions (n = 14). (A) Input-output relationship of ganglion cells in response to current injection in control 
and capsazepine conditions. Curves were normalised to control condition. Spike output on the y-axis is plotted 
against ΔVm, which represents the difference between resting membrane potential and depolarisation potential. 
Capsazepine application produced an obvious right shift in the mean fitted curve from control. (B) Input-output 
relationship of ganglion cells in response to current injection in control and capsazepine conditions. Both 
curves were normalised to 1 and no obvious change was observed. Kolmogorov-Smirnov test showed a 
statistically significant overall difference in the input-output relationship between the two curves (p < 0.0001). 
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3.3.2 Current-to-voltage relationship of ganglion cells 
Whole cell voltage clamp was then used to examine the effect of capsazepine on Na+ and K+ ion 
channels, which reflects the excitability of the RGCs. As previously mentioned, the IV protocol 
used to test the effects of capsazepine on ganglion cell excitability was modified to 18 steps of 
holding membrane potential. Each step was increased by +5mV starting from -75mV to -5mV, 
and +10mV per increment step starting from -5mV to +35mV. The purpose of this protocol 
modification was to produce a better resolution for the IV relationship, especially around the 
activation and peak of the inward Na+ current.   
 
Figure 3.12 shows the normalised mean current-to-voltage response for control and capsazepine 
conditions. Addition of capsazepine caused a significant change in peak Na+ at -45mV from -
2.3±0.1nA in control condition to -1.8±0.6nA (n=12) (Figure 3.13B). However, this change did 
not lead to a significant change in V-half as shown in Figures 3.12 and 3.13A. Also, there was no 
change in peak K+ current (Figure 3.13D).  Though, Figure 3.13C shows that the total number of 
inward Na+ currents was significantly reduced by capsazepine.  
Figure 3.11 Capsazepine produced a non-significant (p > 0.05) 
increase in X-half of ganglion cells. Control condition had a X-half 
value of 16.7 ± 1.0µV, and is very similar to the capsazepine 
condition which had a X-half value of 17.2 ± 1.1µV. 
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To sum up, the reduction in the total number of Na+ events and peak Na+ current suggests a 
decrease of cell excitability was produced by capsazepine. 
 
Figure 3.12 IV response of RGC in control and capsazepine conditions (n = 14). IV relationship shows a 
larger Na+ current at a lower holding membrane potential under the influence of capsazepine. Amplitude of 
Na+ current entry was plotted against membrane potential of RGCs to produce IV curves. Average IV curves (± 
SEM) were normalised to the peak Na+.   
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Figure 3.13 Application of the TRPV1 channel antagonist capsazepine changes RGC excitability. Population 
data are shown. (A) A significant (p < 0.05) reduction in the total number of Na+ events were observed with 
capsazepine. (B) The peak Na+ amplitude was significantly (p < 0.05) less negative in capsazepine condition. 
(C) Capsazepine caused no significant (p > 0.05) change in V-half. (D) A non-significant (p > 0.05) reduction 
in K+ current is produced by bath application of capsazepine. 
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3.4 The effects of URB597 and URB597+Capsazepine on ganglion cell excitability 
properties in TRPV1-/- mice 
In order to further test whether or not the observed effects of capsaicin and capsazepine were due 
to a specific effect on TRPV1 channels, recordings were obtained from RGCs of TRPV1-/-  mice. 
A total of 48 RGCs from TRPV1-/- animals were successfully patched, of which 20 cells 
underwent pharmacological treatment with the FAAH inhibitor URB597, which increases the 
endocannabinoid concentration by blocking the degrading enzyme of anandamide. Although all 
cells were attempted with capsazepine application, only 13 were successfully recorded, had good 
cell access and remained healthy after co-application of URB597 and capsazepine. Due to the 
above stringent criteria, as a result, data presented in this section of the thesis is limited. Current 
injection and current-to-voltage protocols were similar to those employed in Section 3.3.  
In addition to the current-injection and voltage-clamp protocols, light stimulation was also carried 
out with a full field flash with a blue LED to investigate the effects of drugs on the physiological 
responses of RGCs. A total of ten RGCs displayed responses to light stimulation. In these 
experiments, two different light stimulation protocols were used to record light-evoked responses 
in current clamp mode. In one of these protocols, its luminosity was kept constant whilst stimulus 
duration was varied (10 different durations). In the other light-stimulation protocol, five repeats of 
a stimulus of constant luminosity and time duration were delivered to determine an average value. 
Thus, comparisons could be made between control and treatment conditions. Spike count and the 
amplitude of light-evoked postsynaptic potentials were quantified to produce input-output 
functions.  
 
3.4.1 Input-output relationship in response to current injection 
Figure 3.14 illustrates the input-output curve of ganglion cells in the control condition produced 
by current injection protocol, for URB597 (1µM) and co-application of URB597 (1µM) with 
capsazepine (10µM) conditions. Comparison between the three groups was made separately 
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because the total number of cells obtained in URB597 and capsazepine conditions was different 
due to the difficulties of keeping the cell healthy for the full pharmacological protocol to allow 
co-application with capsazepine. In Figure 3.14A and 3.14C, spike output obtained from drug 
conditions were normalised to their previous condition to compare maximum spike output. On the 
other hand, in Figure 3.14B and 3.14D, responses collected during drug conditions were 
normalised to their maximum spike output in order to compare any changes in X-half values. 
 
In Figure 3.14A, the input-output function that after application of URB597 (1µM) shows a 
reduction in the maximum spike output compared to the control condition. Figure 3.16A shows 
plots comparing the maximum number of spikes between the two conditions, statistical 
comparison indicates that URB597 produced a significant drop from 13.0 ± 0.8 spikes to 11.7 ± 
0.9 spikes is shown (n=18), denoting decreased cell responsiveness. When mean input-output 
function of URB597 condition was normalised to maximum spike output of control condition in 
Figure 3.14B, the X-half of the mean input-output curve of both control and URB597 conditions 
were displayed around 20mV. Thus, bath addition of URB597 (1µM) to the retina led to no 
change in X-half, which was confirmed to be statistically insignificant by the Wilcoxon test 
(n=18) shown in Figure 3.15B.  
 
After administering capsazepine (10µM) to the bathing medium, a total of five minutes of waiting 
time was allowed before recording resumed. Under co-application of URB and capsazepine, a 
further reduction of 40% of normalised spike output can be observed in Figure 3.14C. By 
examining the maximum spike output of both conditions, a significant change from 12.2 (± 1.1) 
to 9.0 (± 0.8) spikes were observed (Figure 3.16B, n=11). Figure 3.14D demonstrates no change 
in the average input-output curve. Wilcoxon test in Figure 3.15B confirms the observation in 
Figure 3.14D, showing no change in the X-half value between URB597 and co-application of 
URB597 and capsazepine conditions. Previous results from the Vision lab in wild-type mice had 
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shown that the left shift induced by URB597 could be reversed by co-application of URB597 and 
capsazepine, indicating the involvement of TRPV1 channels. This effect was absent in the current 
study with TRPV1-/- mice, suggesting that in the absence of TRPV1 channels, capsazepine was 
not effective in reversing the effects of URB597. Moreover, Kolmogorov-Smirnov test indicates 
the difference in the general shape of the input-output functions. Kolmogorov-Smirnov test was 
performed comparing the curves in Figure 3.14 B and D, when the input-output functions were 
normalised to the maximum. Although no significant change was found in X-half, Kolmogorov-
Smirnov test showed differences between the control, URB597 and co-application of URB597 
and capsazepine conditions. 
 
In conclusion, in the TRPV1-/- mice, capsaicin produced a decrease in RGC responsiveness. Co-
application of URB and capsazepine could not reverse this effect, and further reduce the output of 
RGC. Moreover, there is no change in x-half for both capsaicin and co-application of URB and 
capsazepine.    
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Figure 3.14 Current injection responses of ganglion cells in control, URB597 and URB597+Capsazepine (URB+CPZ) conditions (n = 10, n = 5 respectively). (A) Input-output 
relationship in response to current injection in control, and URB condition was normalised to its control values. Spike output on the y-axis is plotted against ΔVm, which represents the 
difference between resting membrane potential and depolarisation potential. A reduction in RGC output can be observed upon application of URB597. (B) Input-output relationship in 
response to current injection in control and URB conditions, normalised to maximum spike output. A left shift of URB in input-output function is demonstrated. Kolmogorov-Smirnov test 
showed a statistically significant overall difference in the input-output relationship between the two curves (p < 0.0001). (C) Input-output relationship in response to current injection in 
URB and URB+CPZ conditions, normalised to control condition. A large decrease in RGC output can be observed by co-application of URB and CPZ. (D) Input-output relationship in 
response to current Injection in URB and URB+CPZ conditions, normalised to maximum spike output. Although there was no obvious shift can be seen, however, Kolmogorov-Smirnov 
test showed a statistically significant overall difference in the input-output relationship between the two conditions (p < 0.0001). 
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Figure 3.15. X-half comparison between control, URB597 and capsazepine conditions. Both URB and 
capsazepine produced little change in X-half values (p > 0.05).   
Figure 3.16 Maximum spike output in control, URB597 and co-application of URB597 and capsazepine 
conditions (n=18, n=11 respectively). A significant drop in the average number of spikes from 13.0 (± 0.8) to 
11.7 (±0.9) from control to URB condition could be observed (p ˂ 0.05). When comparing between URB and 
URB+CPZ, the mean change decreased from 12.2 (± 1.1) to 9 (± 0.8) spikes (p ˂ 0.001). 
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3.4.2 Input-output relationship of ganglion cells in response to light stimulation  
In order to test the effects of URB597 and Capsazepine on the synapses where RGCs receive 
their inputs and where the eCB system is mostly localised to, light responses were recorded 
under current clamp mode. A full-field flash of constant light intensity with increments in 
time duration from 5.25 ms to 192.5ms was used to stimulate the RGCs. Input-output 
functions were constructed in the similar fashion of those in current injection protocols, with 
normalised spike output (y-axis) against light-evoked postsynaptic potential (x-axis). When 
this stimulation protocol was applied, as opposed to the current injection protocols, the first 
one or two sweeps of light stimulation did not elicit any spike output in some RGCs. This 
lack of responsiveness in the first few sweeps was reflected in the input-output function as 
the curve started increasing in y-value (normalised spike output) at around 10mV LE-PSP, 
rather than from the origin (0mV). After addition of URB597 (1µM), the mean input-output 
function drawn from RGCs responses to URB597 displayed no change in X-half as shown in 
Figures 3.17B and 3.18A. Also, no change was found in the maximum spike output when 
tested by Wilcoxon test shown in Figure 3.19A. After 5 minutes of co-application of 
URB597 and capsazepine, the curve appeared to have shifted to the left (Figure 3.17D). 
Despite the visually apparent shift, X-half values did not show any statistical difference 
between the tested conditions (Figure 3.18B). Figure 3.19B shows plots of the maximum 
spike output across different drug conditions. As shown in this figure, co-application of 
URB597 and capsazepine led to a significant reduction in spike output, which decreased from 
22.1 (± 4.5) to 16.3 (± 4.1) spikes (p ˂ 0.001, Wilcoxon test). 
To sum up, application of URB produced no change in the light response of TRPV1-/- mice, 
while co-application of URB and capsazepine reduced the number of spikes of RGC in 
response to light.  
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Figure 3.17 Light responses of ganglion cells in control and URB and URB+Capsazepine (URB+CPZ) conditions (n=10, n=5). (A) Input-output relationship in response to 
constant intensity, increasing time duration light stimulation in control, and URB conditions, normalised to control conditions. Spike output on the y-axis is plotted against light 
evoked postsynaptic potential (ΔLE-PSP), which represents the difference between resting membrane potential and depolarisation potential. No obvious change in the average curve for 
control to URB. (B) Input-output relationship in response to light stimulus in control and URB conditions, normalised to maximum spike output. No obvious change can be observed. 
Kolmogorov-Smirnov test showed a statistically significant overall difference in the input-output relationship between the two curves (p<0.0001). (C) Input-output relationship in 
response to constant intensity, increasing time duration light stimulation in URB, and URB+CPZ conditions, normalised to control conditions. A reduction in spike output can be seen 
by URB+CPZ. (D) Input-output relationship in response to light stimulus in URB and URB+CPZ conditions, normalised to maximum spike output. A shift to the left can be observed. 
Kolmogorov-Smirnov test showed a statistically significant overall difference in the input-output relationship between the two curves (p<0.0001). 
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Figure 3.18 Light response X-half values of ganglion cells, comparisons made between control, URB597 and 
capsazepine conditions. Both URB and capsazepine produced no change in X-half values (p > 0.05, Wilcoxon 
test).   
 
Figure 3.19 Maximum spike output of ganglion cells in control, URB597 and co-application of URB597 and 
capsazepine conditions (n=10, n=5) are shown.  There was no significant change in the number of spikes in 
control or URB condition (p ˂ 0.05). When comparing between URB and URB+CPZ, the mean change 
decreased from 22.1 (± 4.5) to 16.3 (± 4.1) spikes and it was statistically significant (p ˂ 0.001, Wilcoxon test). 
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3.4.3 Responses of ganglion cells to stimuli of constant light intensity and constant 
duration 
To further investigate the effects of URB597 and capsazepine on retinal circuitry, another 
light stimulation protocol was used, with the same light intensity and duration. Spike output 
and amplitude of light-evoked postsynaptic potentials of RGCs were quantified and 
compared between control and drug conditions. Comparisons were made between control and 
URB597, and between URB597 and co-application of URB597 and capsazepine using 
stimuli with constant duration and light intensity. In control condition, light-evoked spike 
output had an average value of 11.4 (± 2.1) spikes and LE-PSP had an amplitude of 13 mV. 
Addition of URB597 (1µM) caused no change in spike output (n = 10, p > 0.1) in the mean 
spike count (Figure 3.20C). In both of these conditions, the average amplitude of LE-PSPs 
was 12 mV (Figure 3.20A). After co-application of URB597 (1µM) and capsazepine 
(10µM), spike output and LE-PSP exhibited no change as shown in Figure 3.20 C and 
3.20D.  
In brief, no change was produced by both URB597 and co-application of URB597 and 
capsazepine on the light response of RGCs in TRPV1-/- mice.  
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Figure 3.20 Ganglion cell responses to constant intensity and duration light stimulation in control, URB597 
and URB+capsazepine conditions. (A) Light-evoked postsynaptic potential in response to constant light 
stimulation are shown for the control, and URB597 conditions. No statistical significant change was found 
between these conditions (p > 0.1, n = 10). (B) Light-evoked postsynaptic potential in response to constant light 
stimulation between URB and URB+capsazepine conditions. No change is observed between them (n = 5, p ˃ 
0.1) (C) Number of spike output in response to constant light stimulation between control and URB conditions. 
No change was found between these groups (p > 0.1, n = 10). (D) Number of spike output in response to 
constant light stimulation between URB and URB+CPZ conditions. Little change was found (p > 0.5, n = 4). 
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3.4.4 IV relationship of ganglion cells in voltage clamp 
To explore the effects of FAAH inhibitor URB597 (1µM) and TRPV1 channel antagonist 
capsazepine (10µM) on membrane excitability properties of ganglion cells in the absence of 
TRPV1 channels, current-to-voltage relationships were investigated. 
After addition of URB597 (1µM) to the retina, RGCs were activated at a more 
hyperpolarised potential as shown in Figure 3.21A. This shows that the activation of Na+ 
currents occurs at a lower membrane potential and suggests an increase in cell excitability, 
which was also reflected in the negative change in V-half (Figure 3.22A1). V-half value was 
changed from -50.6 ± 0.9mV to -53.4 ± 1.3mV (p ˂ 0.05, n=17). In addition, both the total 
number of Na+ events and peak Na+ current were significantly reduced upon URB597 
application. After URB597 application, a significant reduction from 146.8 ± 1.8 to 133.3 ± 
29.97 spikes was seen (p ˂ 0.05, n = 17, Figure 3.22B1). Capsazepine caused a further 
significant reduction from 135.4 ± 12.6 to 114.1 ± 13.81 spikes (p ˂ 0.05, n = 12, Figure 
3.22B2). As shown in Figure 3.22C1, peak inward Na+ current had a reduction from -2.7 ± 
0.2nA to -2.1 ± 0.2nA with URB application (p ˂ 0.005, n = 17), and no significant change 
was observed after co-application of URB597 and capsazepine. Finally, K+ peak current did 
not change with URB597 application, but it was reduced from 1.9 ± 0.2nA to 1.4 ± 0.2nA 
under URB+CPZ condition (p ˂ 0.005, n = 12) (Figure 3.22D1 and 3.22D2).   
In conclusion, a reduction in V-half value was observed with URB application, while 
capsazepine had no effect. The total number of Na+ events in control, URB, URB+CPZ 
conditions decreased. Peak inward Na+ currents had a reduction after URB application, while 
no change was present under URB+CPZ condition. Peak outward K+ had no change under 
URB condition, and a significant reduction could be seen under URB+CPZ condition.   
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Figure 3.21 IV response of RGC in control, URB597 and URB+capsazepine conditions. (A) 
Control vs URB IV relationship of ganglion cells showed a larger Na+ current at a lower 
holding membrane potential under the influence of capsazepine (n = 18). Amplitude of Na+ and 
K+ currents were plotted against membrane potential of RGCs to produce IV curves. Average IV 
curves (± SEM) normalised to peak Na+ are shown. (B) URB vs URB+CPZ IV relationship 
illustrated little/no change in capsazepine condition (n = 12). 
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Figure 3.22. Application of FAAH inhibitor URB597 and TRPV1 channel 
antagonist capsazepine changes RGC excitability. (A1, A2) A significant reduction 
in V-half value was observed with URB application, from -50.6 ± 0.9mV to -53.4 ± 
1.3mV (p ˂ 0.05, n = 17). There was no change in V-half after capsazepine was applied. 
(p ˃ 0.05, n = 12). (B1, B2) Total number of Na+ events in control, URB, URB+CPZ 
conditions. A significant reduction from 146.8 ± 1.8 to 133.3 ± 29.97 spikes after URB 
application was observed (p ˂ 0.05, n = 17). Capsazepine caused a further significant 
reduction from 135.4 ± 12.6 to 114.1 ± 13.81 spikes (p ˂ 0.05, n = 12).  (C1, C2) Peak 
inward Na+ currents in control, URB, and URB+CPZ conditions. A reduction was 
observed from -2.7 ± 0.2 to -2.1 ± 0.2nA after URB application (p ˂ 0.005, n = 17). No 
change was present under URB+CPZ condition (p ˃ 0.05, n = 12).  (D1, D2) Peak 
outward K+ currents in control, URB, and URB+CPZ conditions. Little/no change was 
present under URB condition (p ˃ 0.05, n = 17). A significant reduction from 1.9 ± 0.2 
to 1.4 ± 0.2nA could be seen under URB+CPZ condition (p ˂ 0.005, n = 12).   
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The tables below sum up all the changes observed in the Results section. Table 3.1 provides 
a summary of the input-output function including the observed shift, mean change in X-half, 
and its’ significance, as well as Kolmogorov-Smirnov test results. Overall, there was no 
change in the X-half value, despite all Kolmogorov-Smirnov tests showed significant 
differences in the general shape of the sigmoidal curves. In table 3.2, the parameters drawn 
from the I-V relationship were compared between control and drug conditions. A leftward 
shift in the I-V curve indicates increased excitability, which was shown for capsaicin 
condition in the wild-type animals and the URB597 condition for the TRPV1-/-  animals. 
This leftward shift consequently led to decreased value in V-half for capsaicin and URB597 
conditions. A reduction in the magnitude of Na+ currents could be observed for all the drug 
conditions. As for Na+ events, capsazepine (wild-type), URB597 (TRPV1-/- ), and co-
application of URB697 and capsazepine reduced the number of Na+ events. However, no 
change in K+ current was found in any of the drug conditions.  
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Table 3.1. Summary of input-output function of retinal ganglion cells to different drug conditions. Current-clamp was used for generation of table 3.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drug conditions 
Hypothesis of cell 
excitability 
Observed shift Mean change in 
X-half(mV) ± 
SEM 
Significance:         
X-half (Wilcoxon 
test) 
Significance:          
X-half/V-half 
(Kolmogorov-
Smirnov test) 
Capsaicin 
(wild type) 
Increase - 
 +0.49±0.59 
ns **** 
Capsazepine 
(wild type) 
Decrease - 
 +0.45±0.39 
ns **** 
URB597 to 
URB+Capsazepine 
(TRPV1-/- ) 
No change to decrease 
- to -  -0.98±0.86 to                     
-0.27±0.11 ns to ns **** 
Light Response:   
URB597 to 
URB+Capsazepine 
(TRPV1-/- ) 
No change to decrease 
NA to -  NA     to                    -1.9±1.3  
NA to ns **** 
*p < 0.05 **p < 0.01 ***p < 0.001; ← Leftward/Additive shift; → Rightward/Subtractive shift 
NA=not applicable, due to small sample size 
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Table 3.2. Summary of current-to-voltage of the retinal ganglion cells to different drug conditions. 
 
 
*p < 0.05 **p < 0.01 ***p < 0.001; ← Leftward/Additive shift; → Rightward/Subtractive shift 
 Drug conditions 
 
Observed 
shift 
Mean 
change 
in V-half 
(mV) ± 
SEM 
Significance  
V-half 
(Wilcoxon 
test) 
Mean change 
in max 
amplitude of 
Na⁺ Current 
(nA) 
Significance: 
max amplitude 
of Na⁺ Current 
(Wilcoxon 
test) 
Mean 
change in  
total 
number of 
Na⁺ events 
Significance: 
total number 
of Na⁺ events 
Mean change 
in max 
amplitude of 
K⁺ Current 
(nA) 
Significance: 
max 
amplitude of 
K⁺ Current 
(Wilcoxon 
test) 
Capsaicin 
(wild type) ← -3.5±1.3 * +0.51±0.21 * -16.5±8.3 ns -0.257±0.47 ns 
Capsazepine 
(wild type) 
-               -
1.2±1.2 
ns  +0.56±0.21 * 
 -31.57±12.4 * 
-0.029±0.177 ns 
URB597 to 
URB+Capsazepin
e 
(TRPV1-/- ) 
← to - 
                
-2.8±1.1 
to 
2.4±1.7 
* to ns  +0.61±0.17 to +0.27±0.12 ** to *  -13±5.5 to 
-21±8.0 * to * 
-0.41±0.13 ns  
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4. Discussion 
This study aimed to characterise the potential role TRPV1 channels play in retinal ganglion 
cell excitability. Two experimental conditions were examined in RGCs of wild-type animals 
using: 1) capsaicin, a TRPV1 agonist and 2) capsazepine, a TRPV1 antagonist. Another 
experimental approach was to study the modulation of the eCB system in TRPV1-/- animals 
that lacked TRPV1 channels. In this set of experiments, URB597, a blocker of the degrading 
enzyme of the eCB anandamide was used to elevate anandamide concentration. This was 
followed by co-application of URB597 and capsazepine to further investigate whether 
TRPV1 channels are the target protein involved in modulating RGC excitability by eCB. The 
results of the current study suggest TRPV1 channels are tonically activated, although they do 
not seem to be the only target of anandamide that contributes to the modulation of RGC 
excitability. Other membrane proteins, such as NKCCl or TRPM channels, might potentially 
contribute to the changes seen in RGC excitability by anandamide and will be considered 
later in this Discussion section.  
 
4.1 TRPV1 channel modulates retinal ganglion cell excitability 
4.1.1 Activation of TRPV1 channel increases RGC excitability at a low cell input 
Our results indicated no change in X-half for I-O function in RGCs of wild-type mice with 
capsaicin application, but a change in the overall shape of the input-output relationship. A 
Kolmogorov-Smirnov test was used to compare the shape of the two sigmoidal fits 
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(normalised to 1), and this test indicated statistical significance between control and capsaicin 
conditions. Although there was a lack of change in X-half value, RGCs displayed an 
increased spike output in the early phase of the curve in response to small changes in ΔVm. 
These changes indicate that a weaker depolarisation led to a bigger spiking output which 
means there is an increase in cell excitability of ganglion cells. This partially agrees with our 
hypothesis postulating that capsaicin increases cell excitability. Previous findings from our 
lab on the effects of URB597 (Protti D.A., 2015, Yates, 2014, Yong, 2016) showed an 
increase in cell excitability. The hypothesis of our current study stated that application of 
URB597 would raise the level of anandamide. Anandamide is an endovallinod, and it acts on 
TRPV1 channels by allowing influx of Ca2+ ions into the cell which in turn would increase 
cell excitability (Caterina et al., 1997). Thus, the increase in cell output in the initial phase of 
the input-output function by directly activating TRPV1 channels using capsaicin is aligned 
with previous studies and supports the working hypothesis. However, this effect was not 
observed for the whole of the input-output function, namely larger depolarisations did not 
elicit more action potentials. One possible explanation for the above observation is that 
current injection was held for 0.5 seconds. This prolonged stimulation would have caused 
plateau depolarising responses in some RGC with large current injections. In other words, 
responses saturated after a certain level of stimulation. Thus, a protocol modification was 
carried out for the later experiments, by shortening the stimulation time to 0.1 seconds. This 
change in protocol resulted in less spike output, a much smaller change in plateaued 
depolarisation response, and larger depolarisation. Another possible explanation could be a 
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result of the compartment-specific effect of capsaicin. In other CNS regions such as the 
dentate gyrus, anatomical evidence suggests that CB1 and TRPV1 are co-localised (Cristino 
et al., 2006).  Chávez et al. (2014) demonstrated that by activating TRPV1 with capsaicin or 
anandamide, somatic but not dendritic inhibitory transmission was reduced in rat and mouse 
dentate gyrus. The same group also found that the depressing effect on somatic inhibition was 
absent in TRPV1-/- mice, suggesting a modulatory role of TRPV1 channels on GABAergic 
synaptic transmission. These results indicate that in the dentate gyrus, the supressive effect of 
TRPV1 channels works in a compartment-specific manner. In relation to our results, only 
somatic whole-cell patch clamp recordings were obtained, where no change in the magnitude 
of depolarisation induced by current injection could be observed. However, as the only 
somatic response was recorded, we could not be certain of what effects might have taken 
place in other compartments, such as the dendrites. Thus, although the effects of capsaicin 
might be compartment-specific, dendritic and somatic responses could potentially show 
different results.   
 
 
4.1.2 Effects of capsaicin on sodium and potassium currents of ganglion cells 
Under voltage clamp mode, RGCs were held at different membrane potentials to measure 
inward Na+ and outward K+ currents. Current-to-voltage (IV) relationships were built from 
sodium and potassium currents and then plotted against corresponding membrane potentials. 
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The recorded membrane potential at which 50% of Na+ current (V-half) occurred was 
measured as an estimation of voltage-gated sodium channels activation. Although this 
measurement does not provide the most accurate parameter to quantify the voltage-dependent 
properties of voltage-gated Na+ channels (such as activation and inactivation constants), it 
allows analysis of the relationship between membrane potential and Na+ channel activation 
whilst being able to carry out current-clamp recordings from the same cell. Experiments 
blocking K+ currents with caesium and tetraethylammonium would be required to obtain 
more accurate recordings of the voltage-dependent properties of Na+ channels, but this would 
preclude measurements of the input-output relationships as action potentials would not 
repolarise in these conditions, and therefore spiking behaviour would be markedly affected. 
The conditions of the voltage-clamp recordings in this study are therefore a compromise that 
at least allowed measurement of an estimate of the voltage-dependence of Na+ channels 
whilst being able to investigate RGC excitability in current-clamp conditions. Application of 
capsaicin produced a leftward shift in V-half measured from IV curves, indicating that RGCs 
required weaker depolarising steps to elicit Na+ entry, thus indicating that cell excitability 
was increased. This leftward shift in V-half provides support of the observed shift to the left 
in X-half of the I-O relationship. The peak amplitude of the Na+ current, however, was 
reduced. This finding is not in alignment with our hypothesis. One possible explanation is 
that it could be due to the reduction in cell access resistance. In order to analyse the effects of 
capsaicin, a total of five minutes’ drug perfusion time was allowed to fully deliver the drugs 
through the retinal tissue. Patch clamp recordings are very sensitive and once the cell 
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membrane is patched, any changes in the external environment or the perfusion system can 
disrupt the quality of recordings, thus affecting cell responses. Although we have eliminated 
cells that had more than 30% reduction in access resistance and a change of >200pA in leak 
current, several cells still had around 10% reduction in access resistance which could 
potentially result in the observed decrease in Na+ current amplitude. Patch clamp is a 
challenging technique with relatively low success rates, and after exclusion of many cells, the 
total sample number in this study was not as high as in the initial experimental design. 
In regard to K+ channels, little change was observed after capsaicin application. This finding 
is also in contradiction with our initial hypothesis which predicted that capsaicin would 
increase ganglion cell excitability. Previous experiments found that URB597 application 
caused a significant increase in late-stage potassium current in large RGCs but not small 
RGCs (Protti D.A., 2015, Yates, 2014, Yong, 2016). A possible explanation for the lack of 
effect in this study is because of unintentional sampling bias. Although cells were randomly 
patched, it is possible that many of the cells we recorded from did not express TRPV1 
channels as a recent study (Jo et al., 2017) showed that only around 17% of RGCs express 
TRPV1 channels. Given that in this study, a total of 76 RGCs were successfully patched but 
only 25 of them could be classified into cell types, we cannot provide an estimate of whether 
or not they expressed TRPV1 channels. Several challenges such as tissue degradation can 
occur during treatments of retinal tissue for immunocytochemical staining. Tissue was 
initially fixed for 30 minutes then incubated in antibody solutions for at least a week. 
Because of tissue degradation and/or tearing of the tissue due to its fragile nature, only one-
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third of the recorded RGCs were successfully imaged under a confocal microscope. Using 
their morphological features, they were classified into cell types according to criteria used by 
Sun and colleagues (2002). Because of a low sample number, it was not possible to link RGC 
cell types to their physiological responses for statistical comparisons. Hence, the lack of 
change in K+ current might be due to the RGCs recorded were mostly small cells although 
they were randomly selected for recordings.  
The previously observed K+ current modulation by anandamide could be due to its binding to 
CB1R mediated Na+-K+-2Cl--co-transporter (NKCC) 1 channels. Miraucourt and colleagues 
(2016) demonstrated an increase in RGC excitability after blocking NKCC1 using NKCC1 
inhibitor bumetanide in Xenopus tadpoles. The NKCC1 co-transporter has also been localised 
in rodent ganglion cells (Vardi et al., 2000), which suggests its possible involvement in 
modulating cell excitability in mouse RGCs.  
 
4.1.3 TRPV1 channels in Ganglion cells are tonically active  
The TRPV1 antagonist capsazepine was used to investigate the effects of TRPV1 channel 
inactivation on RGCs responses and excitability properties. Similar to experimental 
procedures with capsaicin, RGCs were recorded in current- and voltage-clamp mode, and 
input-output relationships and current-to-voltage relationships were normalised and pooled to 
estimate RGC excitability. The hypothesis predicted that by blocking TRPV1 channels using 
capsazepine, RGC excitability would be reduced.  
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Results from experiments in current clamp conditions showed decreased cell excitability as 
observed in the input-output curves. When I-O relationship of capsazepine condition was 
normalised to the control, a decrease in spike output was observed as the KS test showed the 
difference in curves. This decrease in cell excitability caused by capsazepine supports the 
hypothesis that anandamide acts through TRPV1 channels. Anandamide is a potent agonist of 
TRPV1 channels, and capsazepine being the TRPV1 channel antagonist, competes with 
anandamide for binding. Blocking of TRPV1 channels by capsazepine leads to a reduction in 
Ca2+ influx (van der Stelt et al., 2005) and activation of second messenger pathways that 
modulate RGC excitability. To our surprise and contrary to our hypothesis, no change in X-
half could be observed. Capsazepine is an antagonist, rather than an inverse agonist of TRV1 
channel, and consequently its inhibitory effect is affected by the amount of anandamide 
present. Previously, Leung (2016) demonstrated that URB597 application to retina whole 
mounts increased cell excitability presumably by increasing the levels of anandamide as this 
effect could be reversed by co-application with capsazepine. Furthermore, the IV relationship 
also showed reduced RGC excitability. Although V-half did not have a significant change, 
the reduction in cell excitability was reflected as a significant reduction in the total number of 
Na+ events. Besides, the peak Na+ current was significantly reduced in size. Similar to the 
effects found with capsaicin, there was no change in potassium currents.  
 
In summary, attenuation in spike output, decreased peak Na+ current, and total number of Na+ 
events confirmed the hypothesis of a reduction in cell excitability under capsazepine 
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conditions. However, contrary to our prediction on the hypothesis, no change in X-half, V-
half and peak K+ currents were observed.  
 
4.2 The endocannabinoid anandamide modulates cell excitability in the absence 
of TRPV1 channels 
4.2.1 Anandamide increases cell excitability in the absence of TRPV1 channel 
TRPV1-/- mice were used to investigate the effects of anandamide modulating the retinal 
levels of eCBs in the absence of TPV1 channels. The effects of raising anandamide levels 
with URB597 on RGC excitability were first examined. Co-application of URB597 and 
capsazepine was subsequently used to investigate whether a reversal effect would still be 
present in the absence of TRPV1 channels.  
 
Input-output relationship with application of URB597 and co-application of capsazepine 
As observed in current injection experiments (Results 3.4.1), application of URB597 
produced a decrease in cell excitability in the absence of TRPV1 channels. No change in X-
half was observed, and a significant reduction in cell output was observed as the spike output 
was reduced. This reduced excitability is in agreement with our hypothesis. The original 
hypothesis was based on the idea that anandamide activates TRPV1 channels which in turn 
cause increased excitability as TRPV1 channels are found on the cell membrane and 
cytoplasmic reticulum (Turner et al., 2003). Furthermore, it was proposed that activation of 
the membrane TRPV1 channels would increase Ca2+ influx, and activation of TRPV1 
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channels in the cytosolic compartment would cause an increase in intracellular Ca2+ leading 
to an increase in cell excitability. In addition to being an eCB, anandamide is known to be an 
endovanilloid (Starowicz et al., 2007, Zygmunt et al., 1999) which binds to TRPV1 and 
increases Ca2+ currents into the cell. This increase in intracellular Ca2+ concentration is 
known to modulate Na+ channel phosphorylation (Auld et al., 1988), leading to a change in 
cell excitability. Previously, it was demonstrated a paradoxical effect of increased spike 
output with decreased synaptic input with application of URB597 and anandamide in RGCs 
of wild-type mice (Protti et al., 2015, Leung, 2016, Yates, 2014). Thus, with TRPV1 
channels absent in the knockout mice, Ca2+ concentration would not increase and no 
downstream effects such as increased cell excitability would be expected.   
 
The results obtained after co-application of URB597 and capsazepine showed a decrease in 
cell excitability. No significant change in X-half was observed, as confirmed by Wilcoxon 
test. However, a significant reduction in the spike output was observed. This reduction in cell 
excitability is contrary to our hypothesis. A possible explanation of this reduced RGC output 
is non-specific binding of TRPV1 agonist and antagonist. Although TRPV1 channel is known 
as the ‘capsaicin receptor’, capsaicin was shown to also exhibit a range of TRPV1-
independent mechanisms such as activation of voltage-gated inward and outward currents, 
and binding to the CB1 receptor (Ryskamp et al., 2014). Likewise, capsazepine was also 
found to produce physiological effects in TRPV1-/- mice. It was found that capsazepine 
exerts antagonism on voltage-activated Ca2+ channels (Docherty et al., 1997), acetylecholine 
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receptors (Liu and Simon, 1997), hyperpolarisation-activated cation channels (Ih) (Ray et al., 
2003), and stimulation of amiloride-sensitive ENaC channels (Yamamura et al., 2004). In 
relation to our results, in the absence of TRPV1 channel, capsazepine may have blocked 
voltage-activated calcium channels and led to a reduction in cell excitability. 
 
4.2.2 The Effect of Anadamide and Capsazepine on Light Response of RGCs in the 
absence of TRPV1 channel  
Using the same current-clamp recording protocol, the effect of light stimulation was 
explored. Stimulation of RGCs using light, the natural stimulus, was employed as a more 
physiological approach to investigate cell excitability. The current injection protocol used in 
previous sections involved a series of injections of depolarising currents into the RGC soma 
to cause a change in membrane potential and consequently elicit firing of action potentials. 
This is different from physiological stimulation as synaptic inputs take place in the dendrites 
rather than in the soma. Given that the retina is a complex yet highly organised structure, 
using light stimulation reproduces the conditions where RGCs receive a collection of 
synaptic signals and its response reflects the effects of the drug on the entire circuitry. 
 
Input-output relationship for light response with application of URB597 and co-
application of capsazepine 
Similar to the results observed with current injection protocols, there was no change in X-half 
upon application of URB597, or with co-application of URB597 and capsazepine, as 
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observed in the I-O functions. As for spike output, URB597 did not cause any effect upon 
application in the TRPV1 knockout animals. Thus, confirming our hypothesis that the 
increase in cell excitability works by anandamide binding to TRPV1 channels. Co-
application of URB597 and capsazepine reduced the spike output significantly, in alignment 
with the results of our current injection protocol. Apart from the previously discussed non-
specific binding of capsazepine, in the case of light stimulation, bleaching of the retinal tissue 
and upstream effects should also be considered. In these experiments, light responses were 
attenuated in order to prevent photoreceptor bleaching. As the retinal pigment epithelium 
layer must be detached for infrared illumination coming from the condenser to illuminate the 
tissue for visualisation of cells, photoreceptor pigment could not be regenerated after 
photoisomerisation, which inevitably led to some degree of bleaching (Werner, 2014). 
Although two neutral density filters were used to attenuate the light stimulation, it was still 
observed in many cases that the cell responses became weaker over time. Thus, only a small 
sample size could be used for the final statistical comparison, which had an impact on the 
statistical power. Secondly, the shift in X-half value could be due to non-specific binding of 
capsazepine (Schmidt, 2009) to voltage-activated Ca2+ channels (Docherty et al., 1997), 
acetylcholine receptors (Liu and Simon, 1997), hyperpolarisation-activated cation channels 
(Ih) (Ray et al., 2003), and/or stimulation of amiloride-sensitive ENaC channels (Yamamura 
et al., 2004). Although capsaicin was widely recognised to be specific to TRPV1 channels, 
Shen and co-workers found that in TRPV1-/- mouse, a complete disruption of ON bipolar cell 
function was present (Shen et al., 2009). Initially, capsaicin-induced responses within rod and 
 87 
cone ON bipolar cells appeared to be indistinguishable from the effects mediated by light and 
mGluR6 antagonist, which pointed in the direction of TRPV1 channel. Though, in TRPV1-/- 
mice, light responses of the ON bipolar cells were unaffected. However, the light responses 
were eliminated in the TRPM knockout animals (Shen et al., 2009). 
 However, only partial reduction of the amplitude of capsaicin amplitude was seen in TRPM-
/- mice, suggesting other possible sensors in ON bipolar cells (Morgans et al., 2009).  As 
bipolar cells are upstream in the retinal circuitry, and the inability of categorising RGC cell 
type into subtypes such as ON or OFF cells due to the nature of the stimuli used in this study 
(full field and short duration), or cell morphology, the response produced could have multiple 
contributors. Thus, non-TRPV1-mediated effects by capsaicin and capsazepine should be 
taken into careful consideration.  
 
Light responses to stimuli of constant light intensity and constant duration under the 
effects of URB597 and capsazepine 
In our experiments, light intensity was kept constant and LE-PSP and action potentials were 
quantified and directly compared across drug conditions. Consistent with the input-output 
functions, application of URB597 did not have an obvious effect on LE-PSP or spike output. 
Different to the input-output function generated from increased stimulation time, no change 
in spike output was observed after co-application of URB597 and capsazepine, although a 
reduction in response was expected. This difference in light response could be due to the 
small sample size, which cause the statistical power to be weak. In fact, only five RGCs were 
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recorded successfully with the co-application of URB597 and capsazepine, which had a 
consistent light response. As previously mentioned, five minutes of perfusion time was 
allowed for drugs to fully penetrate through the retinal tissue. Moreover, a waiting time of 
two minutes was allowed at the beginning of each drug condition. During this period, 
spontaneous activity was recorded. If the recording was stable, there was good access to the 
cell body, and have a similar spontaneous activity to the previous control or drug condition, 
only then physiological recordings will follow. Some of the difficulties during recordings 
also involved the nucleus of RGC tending to move towards the pipette tip due to its position, 
or negative pressure inside the tip causing a great loss of cell access, or a dramatic increase in 
cell spontaneous activity. Such cells together with those that had more than 30% reduction in 
cell access and change in leak current of more than 200pA were eliminated. These were in 
total 27 RGCs.  
 
In conclusion, in the TRPV1-/- mice, URB597 caused no change in RGC excitability, 
confirming the original hypothesis. Also, there was no change in RGC excitability after 
application of capsazepine, which differ to the input-output function. This potentially could 
be caused by the weak statistical power as the number of cells recorded was very small.  
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4.2.3 Anandamide and capsazepine modulate sodium and potassium channel 
kinetics in the absence of TRPV1 channel 
Under voltage clamp configuration, application of URB597 significantly shifted the V-half 
value to the left. This finding indicates an increase in Na+ entry into RGCs at lower 
membrane potentials, which leads to an increase in action potential output, and increased cell 
excitability. This does not support our proposed hypothesis and it is not consistent with the 
input-output function collected using current injection protocol under current clamp setup. 
The increase in cell excitability in the absence of TRPV1 channel could possibly be due to 
binding of anandamide to other ion channels such as CB1R mediated by NKCC1 channel. 
The mechanism of eCB action on NKCC1 transporter was explained by a reduction in 
intracellular Cl- levels in RGCs, which in turn leads to their hyperpolarisation. This 
hyperpolarisation helps voltage gated sodium channels recover faster from their inactivation 
state. This all leads to the acute enhancement of intrinsic excitability of RGCs (Miraucourt et 
al., 2016). This mechanism also increases intrinsic cell excitability through interaction 
between glycinergic inhibition and eCB system involving Cl- homeostasis, without the 
involvement of TRPV1 channels. On the contrary, the total number of Na+ events and peak 
inward Na+ current amplitude was significantly reduced. Because this is a direct comparison 
of the parameter values, although with relatively small sample size, the change in recording 
conditions such as cell access could have had an impact on individual cells responses. As a 
result, this has potentially contributed to the weak statistical difference between these groups. 
Co-application of URB597 and capsazepine produced no effect in V-half value or peak Na+ 
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inward current amplitude, but caused a reduction in the total number of Na+ events. As for 
K+, a significant reduction was observed in the I-V graph upon co-application of URB591 
and capsazepine. It has been demonstrated by Mahmmoud et al. (2014) that capsazepine 
inhibits K+ transport through Na+, K+-ATPase. As our I-V results indicate, this effect was 
seen in the TRPV1 knockout mice but not in wild type animals, suggesting a more prominent 
effect in the absence of TRPV1 channels. Furthermore, capsazepine did not reverse the 
effects produced by URB597 on V-half values. This is in alignment with our hypothesis and 
it also supports a non-reversal effect on input-output relationship as seen in current injections. 
Besides, this also suggests the shift of light response input-output relationship is likely to be 
caused by an upstream effect, rather than directly altering RGC excitability.  
 
4.3 Experimental Limitations 
The current study used patch clamping recordings in whole mount retina to target ganglion 
cells. This method allowed an overall output of the retina to be measured as ganglion cells are 
located at the last laminal layer of the retina before transmitting the final visual signals to the 
rest of the brain. Patch clamp recordings are technically challenging and small alterations in 
the external or internal environment can lead to dramatic changes in electrophysiological 
recordings. It was often noticed after careful analyses post experiments that several cells 
recorded would not meet our stringent inclusion criteria. These include a reduction in cell 
access, or fluctuation in membrane potential. In general, this limited the number of cells we 
could use to be included to the final sample. This is especially true for the TRPV1 knock out 
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animals, where two drugs were perfused requiring much longer recording time.  Moreover, 
the patch clamp technique had limited us to test on specific targets in order to examine on the 
local effects. As retinal cells form highly complex neuronal circuits inside the eye, visual 
stimuli first activate photoreceptors, electrical signals travel through multiple synapses, then 
to the rest of the brain for further processing. In the case of light responses, drugs could bind 
to upstream cells and cause a much more complex effect such as on TRPM channels on ON-
bipolar cells. To investigate whether the drug effects are actually due to presynaptic effects, 
blockers such as NBQX and SR95531 could be used to block glutamatergic and GABAergic 
currents, which isolates RGCs from its’ presynaptic effects. Though, under such conditions, 
light response would no longer be able to be tested. But nevertheless, RGC local responses 
could be valuable and serve as complementary to the findings of our current results.  
 
Another limitation arose from the methodology of the somatic voltage clamp technique itself. 
Most of the electrophysiological recordings are done by patching onto the soma/cell body, 
while most of the synaptic inputs take place at the dendrites. Due to the size of the cell body, 
space-clamp errors occur because of the holding voltage between the soma, dendrites and 
axon are different (Williams and Mitchell, 2008). As Williams and Mitchell (2008) pointed 
out, the somatic voltage clamp cannot control voltage at sites beyond the soma very 
precisely, which leads to inaccuracies in the recordings of synaptic responses. In the case of 
the eCB system it is located precisely in the synapses, with eCB being released from the 
postsynaptic terminal and binding to the CB1 receptors that are predominantly located on the 
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presynaptic terminal. This synaptic localisation of the eCB system, along with RGCs featured 
elaborate dendritic structures would make our results suffer from the space-clamp error as 
currents were injected directly into the soma rather than in the dendrites. Thus, the voltage-
gated sodium channels located on the soma have a stronger influence on voltage clamp 
recordings due to its close proximity to the recording electrode compared to those on the 
dendrites. A solution was proposed by Castelfranco and Hartline (2004) by correcting the 
parameters of voltage-gated conductance.  
 
5. Conclusion and Future Directions 
 
5.1 Summary and Conclusions 
This study contributes to the current understanding of endocannabinoid system and how it 
interacts with TRPV1 channels, as well as revealing the binding properties of TRPV1 
channel agonist and antagonist. The present study demonstrated that TRPV1 channels play a 
crucial role in relation to the endocannabinoid system in RGCs. The endocannabinoid, 
anandamide partially acts on TRPV1 channels to increase cell excitability as application of 
TRPV1 agonist capsaicin produced an increase in cell excitability. Application of URB597, a 
blocker of the enzyme FAAH that hydrolyses anadamide, in the absence of TRPV1 channels, 
however, showed that anandamide also acts on other channels as RGCs were activated at a 
more hyperpolarised potential. Moreover, the originally postulated TRPV1 agonist and 
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antagonist, capsaicin and capsazepine were found to have non-specific binding as the 
application of capsazepine was able to reduce cell excitability in the TRPV knockout mice.  
 
 
5.2 Future Directions 
In addition to TRPV1 channels, recent studies point out to other targets of anandamide that 
may also play crucial roles in modulating RGC excitability, such as NKCC1 channels. 
Further investigations could be carried out to test the effects of anandamide on intracellular 
Cl- levels by using the clomeleon sensor as described by Miraucourt et al. (2016) using 
TRPV1 knockout mice.  Additionally, whether the effects produced by capsaicin, 
capsazepine and anandamide would still be present in TRPM knockout animals should be 
investigated. This would allow insights into how upstream TRPM receptor contributes to 
RGC excitability and retinal circuitry.  
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